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Interest  in  using  optical  methods  in  the  development  of  noninvasive  clinical 
diagnostic  and  therapeutic  techniques  for  brain  diseases  has  widely  increased  due  to  their 
simplicity,  safety,  and  affordability.  The  main  limitations  of  light-based  techniques  used 
for  brain  theranostics  are  the  strong  light  scattering  in  the  scalp  and  skull,  which  cause 
decrease  of  spatial  resolution,  low  contrast,  and  small  penetration  depth.  To  address  this 
challenge,  our  group  has  previously  introduced  a  transparent  nanocrystalline 
yttria-stabilized-zirconia  (nc-YSZ)  cranial  implant  material  which  implant  possesses  the 
mechanical  strength  and  biocompatibility  that  are  prerequisites  for  a  clinically-viable 
permanent  cranial  implant  for  patients.  
v  
This  implant  possesses  the  mechanical  strength  and  biocompatibility  that  are 
prerequisites  for  a  clinically-viable  permanent  cranial  implant  for  patients.  A  potential 
benefit  of  this  optical  window  is  an  improvement  of  light-based  therapeutic  techniques 
that  rely  on  sufficient  light  penetration  to  a  target  embedded  in  tissue  such  as 
photobiomodulation,  photodynamic  therapy,  and  optogenetics.  Another  application  of 
this  optical  window  is  noninvasive  visualization  of  brain  blood  vessels,  hematomas,  and 
small  pathologic  structures  (including  cancerous  growth)  with  high  resolution.  This  is 
important  for  diagnosis  and  treatment  of  many  diseases  such  as  tumors  of  the  brain, 
vascular  pathologies,  and  so  forth.  In  this  dissertation,  I  investigated  (1)  characteristics 
and  durability  of  transparent  nc-YSZ  implants;  (2)  feasibility  of  chronic  brain  imaging 
through  the  implant;  (3)  multimodal  imaging  across  the  implant  to  generate  an 
arteriovenous  vascular  map;  (4)  through-scalp  VIS-NIR  light  delivery  and  microvascular 
imaging. 
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Chapter  1.  Introduction 
From  the  deep  blue  to  the  near-infrared  (NIR)  is  the  region  among  the  wide 
spectrum  of  electromagnetic  waves  that  we  know  as  light.  This  delicate  region  has  a 
distinct  advantage  for  interrogating  biological  tissue  due  to  its  unique  photon  energy 
range  of  0.5–3  eV.  At  energies  above  this  range,  C–C  and  C–H  bonds  dissociate  and 
ionization  can  occur,  while  at  energies  below  this  range,  water  absorption  dominates  the 
transmittance,  preventing  any  specific  targeting  of  molecules 1 .  The  noninvasive 
interactions  with  tissue  of  photons  within  this  energy  range  have  been  used  in  numerous 
approaches  to  assess  brain  health  and  treat  its  diseases.  Some  of  these  treatment  practices 
have  been  used  in  clinical  applications  such  as  photobiomodulation  (for  wound  healing, 
tissue  repair,  anti-inflammatory  therapy 2 ,  and  chronic  traumatic  brain  injury 3 )  and 
photodynamic  therapy  (PDT)  which  is  now  clinically  approved  to  treat  brain  cancer 4 . 
Optical  dissection  of  brain  circuits  methods,  known  as  optogenetic  therapies,  have 
resulted  in  the  treatment  of  Parkinson 5 ,  cocaine  addiction 6 ,  depression 7 ,  chronic  pain 8 ,  and 
laryngeal  paralysis 9  in  animals  and  may  one  day  be  translated  for  use  in  humans.  The  
poor  penetration  depth  of  light,  particularly  in  the  visible  range,  has  limited  the  clinical 
applications  of  these  photosensitizer  activation-based  methods.  For  instance,  PDT  is 
currently  only  used  for  the  treatment  of  superficial  lesions,  or  of  lesions  accessible  during 
surgery  or  through  endoscopy 4 .  Therefore,  bio-optical  technologies  for  adequate  delivery 
of  light  to  the  brain  have  been  rapidly  advancing 10 . 
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Light-based  techniques  have  also  been  used  for  brain  health  assessment. 
Numerous  methods  have  been  widely  developed  and  applied  in  various  brain  disease 
diagnostics.  Imaging  of  brain  microcirculation  (i.e.  blood  flow  in  vessels  <150  μm  in 
diameter),  which  plays  a  critical  role  in  the  physiological  processes  of  tissue  oxygenation 
and  nutrient  exchange,  has  enabled  us  to  noninvasively  extract  morphological  and 
functional  information 11,12 .  Morphological  information  provides  vessel  density,  perfusion 
rate,  vessel  diameter,  and  dynamic  measurements  of  microcirculatory  blood  flow  velocity 
and  blood  cell  concentration 11 ,  while  functional  data  provides  information  on  blood 
oxygenation,  changes  in  metabolism,  regional  chemical  composition,  etc 12 .  Various 
imaging  modalities  have  been  developed  which  are  capable  of  measuring  blood  flow. 
Although  they  have  resulted  in  a  number  of  discoveries,  there  are  notable  drawbacks 
which  should  be  considered  in  developing  a  scalable  and  real-time  method  for  routine 
and  long-term  brain  microcirculation  monitoring.  Indocyanine  green  video  angiography 
(ICGVA)  requires  injection  of  dyes  and  cannot  provide  continuous  assessment  of  vessel 
perfusion 13,14 .  Optical  coherence  tomography  (OCT) 15 ,  photoacoustic  imaging  (PAM) 16 , 
and  fluorescence  microscopy  approaches  like  confocal  microscopy  or  the  two-photon 
variant 17  are  based  on  laser  scanning,  which  is  limiting  to  the  temporal  resolution  and  
field  of  view 18 ,  although  recent  technical  improvements  in  OCT  and  PAM  have  been 
reported  which  provide  sufficient  temporal  resolution  for  epileptic  seizure 
monitoring 19–21 .  Fast  full-field  laser  Doppler  perfusion  imaging  (ffLDPI) 17  cannot  
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simultaneously  provide  microvascular  structural  and  functional  information  due  to  lack  of 
adequate  spatiotemporal  resolution 22 . 
Analyzing  intensity  fluctuations  in  scattered  laser  light,  i.e.  speckles,  has  been 
reported  to  provide  useful  biological  information.  Laser  Doppler,  photon  correlation 
spectroscopy,  and  time-varying  speckle  operate  by  analyzing  speckles  from  a  single  point 
in  the  flow  field  and  thus  require  some  form  of  scanning  to  produce  velocity  maps, 
adding  time  to  the  procedure 17 .  Laser  speckle  imaging  (LSI),  on  the  other  hand,  is  a 
full-field,  real-time,  noninvasive,  and  noncontact  imaging  method  which  is  sensitive  to 
both  the  speed  and  morphological  changes  of  the  scattering  particles,  and  is  capable  of 
mapping  relative  velocity  in  flow  fields  such  as  capillary  blood  flow 17 .  By  utilizing 
spatio-temporal  statistics  of  speckle,  LSI  produces  blood  flow  maps  in  a  fraction  of  a 
second  without  the  need  for  scanning,  making  it  a  true  real-time  technique 17 .  Like  LSI, 
ffLDPI  can  provide  full  field  information  in  a  short  time,  but  LSI  has  the  advantage  of 
being  relatively  simple  and  inexpensive  since  it  does  not  require  a  high-speed  imaging 
array.  This  make  LSI  a  scalable  and  compatible  modality  which  has  been  used  in 
wearable  and  routing  brain  monitoring  applications 23 ,  solely  or  coupled  with  other 
imaging  modalities 17 . 
Proving  theranostic  optical  access  to  the  brain  is  complicated  due  to  the  static  and 
dynamic  effects  of  optical  scattering  and  absorption  by  the  inhomogeneous  skull  and 
scalp  tissues.  These  effects  drastically  limit  the  achievable  imaging  field  of  depth  and 
resolution.  Therefore,  brain  imaging  has  been  predominantly  demonstrated  in  rodent 
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open-skull  and  thinned  skull  models.  Likewise,  in  our  research  team  prior  studies  we 
have  found  that  optical  imaging  through  the  intact  skull  of  mice  diminishes  detection  of 
the  intrinsic  optical  signals 24–27 .  Moreover,  the  optical  properties  of  the  inhomogeneous 
cranial  bone  overlap  with  those  of  brain  tissue  and  jointly  these  factors  decrease  the 
accuracy  and  reliability  of  the  data.  Studies  in  the  literature  have  addressed  this  optical 
barrier  with  various  approaches  including  imaging  the  brain  directly  with  an  opened 
skull 28 ,  thinned  and  polished  skull  preparations 29,30 ,  temporary  optical  clearing  of  the  skull 
using  optical  clearing  agents 31–33 ,  and  implanting  glass  or  PDMS  windows 34,35 .  Glass  and 
PDMS  windows  are  powerful  research  techniques,  but  are  not  appropriate  for  human 
application  as  permanent  cranial  implants  for  patients.  Like  skull  thinning  and  polishing 
techniques,  glass-based  windows  compromise  protection  for  the  brain  due  to  the 
extremely  low  fracture  toughness  of  typical  glasses  (KIC  =  0.7-0.9  MPa  m1/2) 36  which  
increases  potential  for  catastrophic  failure  by  fracture,  while  the  effect  of  skull  optical 
clearing  agents  for  long-term  use  on  human  skull  is  still  unknown 24 .  A  number  of 
biomedical  considerations  including  biocompatibility,  mechanical  strength,  and  ageing 
should  be  examined  in  order  to  create  an  optical  window  for  eventual  clinical 
application 24 .  Conventional  cranial  prosthesis  including  titanium,  alumina,  and  acrylic 37 , 
have  not  provided  the  requisite  combination  of  transparency  and  toughness  required  for 
clinically-viable  transparent  cranial  implants.  To  address  this  challenge,  our  group  has 
previously  introduced  a  transparent  nanocrystalline  yttria-stabilized-zirconia  cranial 
implant  material,  which  possesses  the  mechanical  strength  and  biocompatibility  which 
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are  prerequisites  for  a  clinically-viable  permanent  cranial  implant  for  patients 24–27,38–46 . 
This  implant  has  been  referred  to  in  the  literature  as  the  “Window  to  the  Brain”  (WttB) 
implant.  Figure  1.1  shows  an  illustration  of  implant  placement  envisioned  in  eventual 
human  application  providing  theranostic  optical  access  for  light  delivery  and  high 
resolution  and  chronic  brain  monitoring  without  scalp  removal. 
 
Figure  1.1.  Illustration  of  the  Window  to  the  Brain  cranial  implant 
concept.  The  implant  will  be  attached  to  the  skull  beneath  the  scalp.  The 
application  of  optical  clearing  agents  will  allow  for  optical  transmission  to 
and  from  the  brain  without  scalp  removal. 
 
My  preliminary  studies,  reported  in  detail  in  chapter  2,  have  established  the 
essential  feasibility  of  the  WttB  concept  by  demonstrating  the  excellent  ageing  resistance 
of  nc-YSZ  implants  and  showing  they  can  withstand  long‐term  implantation  conditions 
without  exhibiting  change  in  optical  and  mechanical  properties.  
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We  have  previously  shown  that  this  implant  allows  for  increased  imaging  depth 
and  contrast  compared  to  the  native  skull  for  optical  coherence  tomography  (OCT) 39 .  In 
chapter  3,  I  sought  to  expand  upon  previous  indications  that  this  WttB  implant  allows  for 
improved  LSI  spatial  resolution  of  brain  blood  flow  compared  to  imaging  through  the 
native  skull  in  mice 25 .  In  addition,  our  previous  OCT  study  was  acute  in  nature  and  did 
not  assess  whether  imaging  quality  across  the  WttB  implant  is  maintained  over  time. 
Therefore,  Chapter  3  demonstrates  repeated  brain  imaging  using  both  OCT  and  LSI 
across  the  WttB  implant  over  4  weeks  to  determine  if  the  WttB  implant  allows  for 
chronic  OCT  imaging. 
In  chapter  4,  I  demonstrated  that  LSI  combine  with  multispectral  reflectance 
imaging  (MSRI),  allows  for  distinction  between  veins  and  arteries  in  the  vascular  flow 
maps  produced  by  LSI.  This  creates  an  arteriovenous  vasculare  map,  vein‐artery 
separation,  information  which  is  of  value  scientifically  and  medically.  By  applying  this 
combined  technique  to  mouse  cerebral  vascular  network  in  vivo,  I  compared  imaging 
through  the  skull,  to  the  brain  directly  through  a  craniectomy,  and  through  a  transparent 
cranial  “Window  to  the  Brain”  (WttB)  implant. 
Some  spectral  regions  in  the  Near  Infrared  (NIR)  spectral  range  (800  to  2500  nm) 
offers  low  scattering  and  absorption  as  well  as  a  deep  penetration  depth  in  tissue 
media 47–49 .  Because  of  these  features,  some  spectral  windows  within  the  NIR  wavelength 
range  have  shown  promising  results  for  brain  studies,  including  deep  imaging, 
diagnostics  and  therapeutic  applications  in  brain  diseases 50–53 .  Different  optically 
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transparent  spectral  windows  for  head  tissues  have  been  identified  within  the  NIR 
spectral  range.  These  wavelength  windows  avoid  light  attenuation  by  the  tissue  due  to 
water  absorption  peaks  located  at  1450  nm  and  1940  nm 54–56 .  In  chapter  5,  I  reported  on 
the  enhancement  in  optical  access  provided  by  the  transparent  YSZ  implant  for  brain 
studies  in  the  NIR  wavelength  range.  Because  this  cranial  implant  is  sought  as  a  means  to 
obtain  optical  access  for  post-operatory  and  prolonged  diagnostics  and/or  therapy 
purposes,  scalp  scattering  must  be  overcome.  In  this  context,  I  also  evaluated  the  use  of 
optical  clearing  agents  (OCAs)  in  the  scalp,  particularly  their  effects  on  the  optical 
transmittance  in  the  NIR  spectral  range.  
Visible  wavelength  range  also  shows  promising  features  to  facilitate  various 
photosensitizer  activation-based  therapies.  Photobiomodulation  (600-1064  nm) 1,2,57–59 , 
PDT(405-900  nm,  mainly  in  red  range) 4,60 ,  optogenetic  (400-630  nm) 5,9,61  are  a  few  
examples  of  optical  techniques  that  could  benefit  from  the  improved  light  delivery 
offered  by  WttB  implant  and  scalp  optical  clearing.  In  chapter  6,  the  enhancement  in 
optical  access  to  the  brain  using  scalp  optical  clearing  and  WttB  implant  is  evaluated 
through  comparing ex  vivo  optical  transmittance  measurements  and in  vivo  through-scalp 
brain  hemodynamics  imaging  in  mice. 
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Chapter  2.  Characterization  of  transparent  nanocrystalline 
yttria‐stabilized  zirconia  implants 
Background 
Polycrystalline  zirconia-based  ceramics  have  become  the  focus  of  recent 
investigations  because  of  their  unique  combination  of  properties.  Their  high  hardness  and 
chemical  inertness  (high  temperature  stability  and  corrosion  resistance)  make  them 
important  target  materials  for  various  applications.  Well-proven  biocompatibility,  low 
thermal  conductivity,  and  high  oxygen  diffusivity 62  have  made  zirconia-based  ceramics  a  
favorable  option  for  biomedical  applications.  By  decreasing  the  grain  size  of  the 
polycrystalline  ceramics  to  nano-scale,  novel  characteristics  such  as  high  density  (low 
porosity),  transparency/translucency,  and  high  refractive  index  and  Abbe  number  have 
been  reported. 63–67  
Transparent  nanocrystalline  yttria-stabilized  zirconia  (nc-YSZ)  ceramics 
developed  by  our  research  group  as  biomedical  transparent  cranial  implants  aim  to 
provide  chronic  optical  access  to  the  brain 24,68–73  in  order  to  facilitate  the  diagnosis  and  
treatment  of  neurological  diseases. 39  A  recent  study  also  demonstrated  the  ability  of  this  
implant  to  improve  ultrasound  imaging  of  the  brain  compared  to  imaging  through  skull. 40  
The  transparency  of  the  nc-YSZ  is  achieved  by  using  ultra-fine  yttria-stabilized  zirconia 
(YSZ)  powder  and  an  innovative  ceramic  processing  method,  current-activated 
pressure-assisted  densification  (CAPAD),  leading  to  transparent  nc-YSZ  ceramics. 74  
CAPAD  enables  reduction  of  the  number  of  pores  as  well  as  reduction  of  their 
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dimensions  to  nanometric  scale  and  at  these  length  scales,  porosity  is  sufficiently  small  to 
minimize  scattering  in  the  spectral  range  of  interest  for  medical  imaging  and  laser 
therapies  of  the  brain. 63  
Although  zirconia-based  implants  have  been  known  for  their  excellent  mechanical 
properties,  the  in  vivo  application  was  found  to  be  affected  by  long-term  failures  for  some 
samples  with  micrometric  grain  sizes,  due  to  low  temperature  degradation  (LTD).  By 
contrast,  YSZ  with  nanometric  size  grains  are  significantly  more  resistant  to  LTD. 66  LTD  
is  due  to  a  crystal  phase  transformation  from  tetragonal  to  monoclinic,  which  is 
associated  with  a  volume  increase  of  about  4  -  6%. 75  This  expansion  induces  localized  
compressive  stresses  and  eventually  microcracks  around  the  transformed  zirconia 
particles. 76  These  microcracks  propagate  through  the  sample  bulk,  and  internal  defects  
such  as  pores  and  crack  surfaces. 77  Under  such  conditions,  the  material  loses  its  cohesion  
and  mechanical  properties.  Therefore,  small  amounts  of  porosity  contributes  to  enhance 
the  nucleation  and  propagation  of  the  monoclinic  phase,  so  the  use  of  very  dense  implants 
is  required  to  reduce  the  transformation  rate. 76,78   
As  a  modest  amount  of  transformation  can  change  optical  characteristics  such  as 
transparency,  in  Chapter  2,  we  investigated  the  optical  properties  of  transparent  nc-YSZ 
ceramics  with  different  stabilizer  contents  (Yttria  dopant  levels)  of  3,  6  and  8  mol% 
before  and  after  extended  accelerated  ageing  treatments.  Further,  because  mechanical 
properties  become  compromised  when  LTD  occurs,  we  also  compared  the  hardness  of 
our  samples  before  and  after  the  accelerated  ageing  treatments.  The  treatment  simulates 
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in  vivo  ageing,  according  to  the  ISO  13356:2008  recommendations 77,79  (i.e.  autoclave  
processing  at  134  °C  at  a  water  partial  pressure  of  2–3  bar). 
To  my  knowledge,  this  is  the  first  study  to  compare  the  LTD  of  transparent 
nanocrystalline  YSZ  with  differing  stabilizer  content  (3,  6,  and  8  mol%  Yttria).  Most 
studies  conducted  on  LTD  of  zirconia-ceramic  have  involved  opaque 
micrometric-grained  YSZ.  The  objective  of  this  current  study  is  to  assess  the  LTD  of  new 
nc-YSZ  through  simulated  ageing  protocols,  to  model  how  the  WttB  implant  will 
perform  optically  and  mechanically  over  decades  of  ageing  in  the  body. 
Methods 
Implant  fabrication  and  preparation 
Commercial  (Tosoh  USA  Inc.,  Grove  City,  Ohio)  nanocrystalline  3YSZ,  6YSZ,  and 
8YSZ  powders  (respectively  doped  with  6,  12,  and  16  mol%  nc-YSZ)  with OY 1.5  
reported  crystallite  sizes  of  55  nm,  were  densified  via  the  CAPAD  technique,  to  produce 
transparent  Yttria-stabilized  zirconia  ceramics. 80 In  the  literature,  this  technique  is  often 
called  spark  plasma  sintering  (SPS).  We  used  CAPAD  here  to  emphasize  the  fact  that  it  is 
complementary  contributions  of  the  current  and  an  applied  pressure  that  makes  it 
successful. 80  During  the  fabrication  processes  of  all  samples  for  this  work,  1.5000g  ±  
0.0001g of  starting  powder  was  poured  into  a  graphite  die  of  inner  diameter  measuring  
19  mm,  and  secured  between  two  plungers  with  the  same  outer  diameter.  The  die, 
plungers,  and  powder  assemblies  were  placed  into  the  CAPAD  apparatus  and  secured 
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between  two  graphite  spacers  and  copper  electrodes,  all  enclosed  within  a  vacuum 
chamber.  A  vacuum  of  Torr  was  attained  in  all  cases.  1×10 3−
 All  powder  compacts  were  pre-pressed  to  a  maximum  load  of  30  kN,  applied  
linearly,  to  produce  a  nominal  compressive  pressure  of  106  MPa  on  the  sample,  and  held 
for  2  minutes  to  achieve  a  green  body  of  appreciable  density.  The  load  was  then  released, 
and  the  green  body  subjected  to  another  uniaxial  compressive  stress  of  106MPa  over  a 
3-minute  interval.  Once  the  set-point  temperature  was  reached,  a  second  load  ramp  ( 
)  was  applied.  This  ramp  bringing  the  uniaxial  pressuring  on  the  sample  up  to  kN .min 1−
141  MPa,  was  maintained  for  10  minutes,  the  duration  of  processing,  and  thereafter 
linearly  released.  In  addition  to  the  aforementioned  load  parameters,  the  green  pellet  was 
simultaneously  heated  to  high  temperature  by  applying  electric  current  through  the  die 
and  plunger  assembly,  consequently  creating  joule  heating.  All  samples  were  processed  at 
1200  ̊C,  with  an  average  heating  rate  of  approximately  160  ̊C/min,  from  room 
temperature,  and  held  for  10  minutes. 
 The  density  of  the  samples  was  measured  using  the  Archimedes  method,  and  the  
ASTM  standard  designated  B962-13  was  followed. 81  Grain  size  measurements  of  the  
bulk  sample  made  from  fracture  surfaces  were  evaluated  using  SEM. 
 The  samples  thicknesses  were  reduced  by  polishing  with  30-micron  diamond  slurry  
on  an  automatic  polisher  (Pace  Technologies,  Tucson,  Arizona  USA).  The  two  faces 
were  then  polished  using  progressively  finer  abrasives  (from  30  μm  diamond  slurry  down 
to  0.2  μm  colloidal  silica  slurry)  to  reduce  light  scattering  by  the  implant  surfaces  and 
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thus  increase  transparency  as  well  as  to  create  a  uniform  surface  area  between  different 
samples.  As  ageing  begins  at  surface  and  propagates  into  bulk,  surface  area  is  an 
important  factor  to  control  between  samples  when  comparing  ageing  results.  After 
preparation  process,  the  polished  samples  underwent  ageing  tests. 
Ageing  test 
 The  test  for  simulating  in  vivo  ageing,  per  the  ISO  13356:2008  recommendations  
(ISO,  2008),  uses  hydrothermal  treatment  at  134  °C,  at  a  steam  partial  pressure  of  2–3  bar 
which  is  known  as  autoclave  processing.  As  seen  in  Figure  2.1,  the  samples  were  placed 
in  a  steel  pressure  chamber,  and  saturated  high-pressure  steam  was  generated  by  a  boiler 
and  sent  to  the  sample  chamber  through  an  electronic  valve.  An  electric  heating  jacket 
surrounded  the  chamber  to  prevent  steam  condensation  and  stabilize  the  temperature  at 
134  °C.  Two  K-type  thermocouples  were  used  to  measure  the  sample  chamber  and  the 
boiler  temperature,  and  an  electronic  pressure  sensor  was  connected  to  the  pressure 
chamber.  A  microcomputer  (Raspberry  Pie  3)  coupled  to  the  sensors  controlled  the 
heating  jacket  power  and  the  valve  status.  The  ageing  treatments  were  performed  in 
cycles  of  5,  10,  10,  25,  25,  25  h,  for  a  total  of  100  h  for  each  sample.  At  the  end  of  the 
treatments,  the  samples  were  cooled  down  to  room  temperature  and  dried.  
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 Figure  2.1.  Hydrothermal  treatment  experimental  setup  schematic. 
Samples  were  placed  inside  a  pressure  chamber.  Thermocouples  and 
a  pressure  sensor  coupled  to  a  microcomputer  maintained  the 
temperature  and  pressure  at  134°C  and  2-3  bar. 
 
Material  characterization 
 X-ray  diffraction  (XRD)  analysis  was  used  to  detect  any  phase  transformation  due  
to  the  ageing  treatments  (Figure  2.2(a)).  Due  to  its  simplicity,  this  technique  has  been 
considered  as  a  first  step  to  investigate  the  ageing  sensitivity  of  a  particular  zirconia. 
However,  this  technique  suffers  some  limitations,  such  as  poor  precision  during  the  first 
stages  of  ageing  (which  have  also  been  reported  with  a  much  higher  sensitivity  using 
grazing  incidence  angles  of  1–5°  (2θ)), 77,82  as  well  as  the  absence  of  local  information  on  
ageing  processes. 83  Data  were  acquired  on  an  X-ray  diffractometer  (PANalytical  
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Empyrean  Series  2)  using  a  step  size  of  0.03°  (2θ)  and  an  acquisition  time  of  5s  per  step. 
Various  (hkl)  planes  were  used  to  evaluate  crystal  structures,  including  cubic  (111), 
tetragonal  (101)  and  monoclinic  ( and  111)  peaks  at  30.2°,  30.2°,  28.2°  and 111  11 1
31.5°  (2θ),  respectively.  It  must  be  noted  that  the  distance  between  cubic  and  tetragonal 
peaks  is  smaller  than  the  width  of  the  peaks  which  makes  them  indistinguishable  and 
detected  at  the  same  angle  (30.2°). 
 Raman  spectroscopy  was  additionally  performed  to  investigate  the  impact  of  
ageing  on  the  phase  transformation  (Figure  2.2(b)).  Raman  spectroscopy  has  been 
reported  to  show  higher  sensitivity  to  the  smaller  trace  of  monoclinic  phase, 84 associated 
with  a  higher  lateral  resolution  than  XRD.  Micro-Raman  spectrum  were  recorded  by 
using  a  spectrometer  (Horiba's  LabRam)  with  acquisition  time  of  60s.  The  incident  laser 
light  with  a  wavelength  of  532  nm  was  focused  on  the  sample  within  a  spot  of  10  μm  in 
diameter.  Presence  of  monoclinic  phase  was  assessed  by  comparing  monoclinic  doublet 
at  179  and  190    in  the  Raman  spectra. cm 1−
Optical  characterization 
 To  qualitatively  compare  the  transparency  of  the  densified  and  polished  3YSZ,  
6YSZ,  and  8YSZ  samples,  photographs  of  a  NBS  1963A  resolution  target  (18  cycle/mm 
target,  each  black  line  width  is  27.78  μm)  through  the  ceramics  were  taken  (Figure  2.3). 
For  quantitative  comparison,  optical  transmittance  of  the  nc-YSZ  samples  were  evaluated 
by  optical  spectrometry  in  visible  and  near-infrared  light.  The  optical  transmittance  was 
measured  using  a  white  light  source  (HL2000  FHSA,  Ocean  Optics,  FL)  and  a 
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spectrometer  (SD2000,  Ocean  Optics,  FL)  in  the  500-1000  nm  wavelength  range.  The 
sampling  system  used  for  specular  transmittance  consists  of  a  rail  coupled  with  two  fiber 
holders  including  collimating  lenses  (MP-74-UV,  Ocean  Optics,  FL)  with  a  wavelength 
range  of  185-2500  nm.  A  space  for  placing  the  samples  was  incorporated  on  one  of  the 
fiber  holders.  After  placing  the  sample,  the  fiber  holders  were  fixed  by  screws  to  mitigate 
the  effects  of  ambient  light.  A  couple  of  multimodal  optical  fibers  (P400-2-VIS-NIR, 
Ocean  Optics,  FL)  were  connected  from  the  light  source  to  the  fiber  holder  and  from  the 
other  fiber  holder  to  the  spectrometer.  The  spectra  were  acquired  as  an  average  of  10 
measurements,  with  integration  time  of  100ms.  
 The  normalized  transmittance  was  calculated  considering  the  ratio  of  light  
transmitted  through  the  sample  to  the  total  light  incident  upon  that  sample  (Eq.  (2.1)). 
 (2.1) 
Where  is  transmittance,  is  the  measured  spectral  intensity,  is  the  total  light T  S (λ)  I (λ)  
incident,  and  D  represents  the  reference  in  dark  environment. 
Mechanical  characterization 
 To  compare  the  mechanical  properties  between  the  pristine  samples  and  aged  
samples,  indentation  tests  were  performed  using  a  micro  Vickers  hardness  tester 
(900-391A,  Phase  II  Plus,  NJ).  The  indentation  was  performed  using  loading  force  of  4.9 
N  and  15s  duration.  The  instrument  was  re-calibrated  before  and  after  testing,  by 
performing  a  series  of  indentations  on  a  certified  steel  reference  sample.  The  average 
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value  and  standard  deviation  of  10  indentations  were  calculated  for  each  sample  before 
and  after  the  ageing  treatments. 
Results 
Densified  samples 
 The  density  of  the  CAPAD  processed  samples  (discs  of  1mm  thickness  and  19mm  
diameter)  were  99.8%,  99.9%,  and  99.9%  for  the  3YSZ,  6YSZ,  and  8YSZ  respectively. 
Grain  size  measurements  of  the  bulk  samples  were  made  from  fracture  surface 
measurements  of  SEM  micrographs  and  showed  an  average  grain  size  (AGS)  of  147±45 
nm  across  all  compositions.  The  polished  sample  thicknesses  were  610±1µm,  584±1µm, 
and  601±1µm  for  3YSZ,  6YSZ,  and  8YSZ,  respectively. 
Material  characterization 
 XRD  patterns  of  samples  before  and  after  50  and  100  h  of  accelerated  ageing  via  
hydrothermal  treatment  are  shown  in  Figure  2.2(a).  XRD  patterns  in  the  range  of  28°-38° 
are  shown  in  Figure  2.2(a).  Only  cubic  (111)  and  tetragonal  (101)  (both  peaks  inseparably 
appeared  at  30.2°)  can  be  seen  in  the  XRD  patterns,  confirming  that  there  is  no 
monoclinic  phase  present.  The  peaks  and  patterns  remained  the  same  for  all  samples 
following  ageing  treatments,  indicating  that  no  phase  transformation  occurred.  The  inset 
shows  monoclinic  picks  appeared  after  10h  of  ageing  treatment  in  Axis  Biodental  dental 
implant  control  sample  with  a  conventional  microscale  grain  size.  In  Figure  2.2(b),  the 
comparison  of  micro-Raman  patterns  in  the  100-900 region  shows  stability  of  cm 1−
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tetragonal  and  cubic  phases  after  the  treatments,  further  confirming  that  no  phase 
transformation  to  monoclinic  (doublet  at  179  and  190  )  occurred. cm 1−  
 
Figure  2.2.  For  3YSZ,  6YSZ,  and  8YSZ,  XRD  diffractogram  (a)  and  micro-Raman 
patterns(b),  obtained  after  up  to  100  h  of  hydrothermal  treatment  at  134  °C.  Monoclinic 
peaks  in  the  control  sample  (after  10  h  of  treatment)  are  shown  in  the  inset. 
 
Optical  characterization 
 Figure  2.3  shows  images  of  a  National  Bureau  of  Standards  (NBS)  resolution  
target  imaged  through  the  transparent  nc-YSZ  samples.  All  of  the  samples  clearly  show 
the  highest  resolution  (18  cycles/mm)  on  the  resolution  target  when  transmitted  light  is 
observed  through  them.  As  seen  in  Figure  2.3,  all  the  samples  transmit  light  and  appear  as 
different  shades  of  orange. 
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 Figure  2.3.  Photographs  of  an  NBS  1963A  resolution  target  (a) 
through  the  3YSZ  (b),  6YSZ  (c),  and  8YSZ  (d)  samples.  The 
resolutions  shown  are  the  18  cycle/mm  target  (each  black  line 
width  is  27.78  μm). 
 
 To  assess  any  change  in  optical  properties  due  to  the  accelerated  ageing  hydrothermal  
treatment,  optical  transmittance  of  the  transparent  samples  were  measured  over  the 
wavelength  range  of  500-1000  nm  at  baseline  and  after  50h  and  100h  of  ageing.  Figure 
2.4  presents  the  normalized  optical  transmittance, ,  for  both  pristine  and  aged T (λ)
3YSZ,  6YSZ,  and  8YSZ  samples.  As  shown  in  the  figure,  the  transmittance  curves  for  all 
three  samples  have  approximately  the  same  trend.  However,  for  any  given  wavelength, 
the  transmittance  increases  as  the  Yttria  content  is  increased.  In  addition,  the  samples 
transmit  a  higher  percentage  of  light  as  the  wavelength  of  the  incident  light  is  increased. 
These  results  are  consistent  with  our  previous  measurements,  showing  relatively  low 
transmission  in  the  blue-green  end  of  spectrum  caused  by  absorption  of  oxygen  vacancy 
related  defects. 74 The  inset  in  Figure  2.4  shows  the  maximum  difference  between  the 
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transmittance  curves  between  pristine  and  aged  samples.  The  changes  in  transmittance 
values  after  the  treatments  (compared  to  the  pristine  samples),  were  less  than  3%. 
 
Figure  2.4.  Mean  T(λ)  values  obtained  at  wavelength  range  of  500-1000 
nm  to  compare  the  transmittance  values  of  various  nc-YSZ  samples 
(3YSZ,  6YSZ,  and  8YSZ)  before  and  after  ageing.  The  inset  shows  the 
maximum  difference  in  optical  properties  curves  between  the  pristine  and 
aged  samples. 
 
Hardness  characterization 
 As  the  phase  transformation  to  monoclinic  compromises  mechanical  properties,  
we  compared  the  hardness  of  3YSZ,  6YSZ,  and  8YSZ  before  and  after  ageing.  The 
averaged  results  and  the  standard  deviations  calculated  from  10  indentation  experiments 
per  sample  are  summarized  in  Table  1.1  as  a  function  of  ageing  treatment  time  and  Yttria 
content.  For  the  pristine  samples,  the  highest  hardness  value  was  obtained  for  3YSZ 
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sample.  The  6YSZ  and  8YSZ  samples  had  slightly  lower  hardness  values  (6.64%  and 
4.26%,  respectively).  For  3YSZ  and  8YSZ  samples,  changes  in  hardness  were  not 
significant  (paired  two-tail  t  test),  with  t  values  greater  than  0.05.  For  the  case  of  6YSZ, 
changes  in  hardness  between  pristine  sample  and  sample  after  50  or  100  hours  of  ageing 
treatment  was  found  to  be  significant  (t  =  0.00094  and  0.0037,  respectively),  although 
these  changes  were  small  (less  than  2%  increase  in  hardness  compared  to  pristine 
sample). 
 
Table  1.1.  Hardness  of  the  pristine  and  aged  samples.  Data  is  given  with  standard 
deviation  (statistical  processing  of  multiple  indentations  for  each  sample). 
 
Discussion 
 The  transparent  nc-YSZ  ceramics  evaluated  in  this  study  show  promise  for  medical  
and  non-medical  applications.  By  performing  biocompatibility  tests  and  brain  imaging 
studies,  we  have  demonstrated  the  feasibility  of  this  application. 24,39,40,68–73,85–87  Phase  
transformation  (ageing)  resistance  and  the  effect  of  hydrothermal  treatment  on  optical  and 
mechanical  properties  of  the  ceramics  are  crucial  to  understand  for  any  medical  or 
non-medical  application  of  the  transparent  nc-YSZ  ceramics.  Recently,  fabrication  of 
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translucent  and  transparent  YSZ  with  grain  size  on  the  micro-  and  nano-scale  have  been 
reported. 63,86,88,89  However,  a  thorough  investigation  on  preparation  and  evaluation  of  LTD  
and  its  influence  on  mechanical  and  optical  properties  in  transparent  nanocrystalline 
stabilized  zirconia  ceramics  with  various  Yttria  dopant  levels  of  3,  6,  and  8  mol%  have 
not  been  reported. 
Ageing  caused  by  the  transition  of  the  tetragonal-to-monoclinic  phase  represents  a 
common  problem  of  zirconia  ceramics  stabilized  by  acceptor  dopants.  The  process  is 
triggered  by  the  hydroxyl  groups  (with  bound  –OH)  which  can  penetrate  into  the  lattice 
over  time  through  oxygen  vacancies  resulting  from  the  doping  process. 74 Degradation  due 
to  this  transformation  has  been  known  to  propagate  gradually  to  the  bulk  of  the 
material. 75  Unlike  the  porosity  of  micrometric-structured  stabilized  zirconia  ceramics,  the  
nano-scale  grain  and  high  densities  of  our  nc-YSZ  have  proven  excellently  effective  in 
preventing  the  transformation,  as  shown  by  our  results  here  as  well  as  others. 90,91 
Considering  the  self-ionization  of  water,  a  greater  number  of  ions  produced  at OH−  
higher  temperatures  and  pressures  can  accelerate  the  LTD  process. 92  Accelerated  ageing  
treatment  has  been  a  common  method  to  evaluate  zirconia  ceramic  LTD.  Chevalier  and 
Gremillard’s  evaluation  based  on  actual  observations  of  zirconia  femoral  heads  implanted 
in  vivo  for  4  and  8  years,  showed  that  1h  of  autoclave  treatment  at  134  °C  had  a  similar 
effect  as  a  3-4  years  in  vivo  ageing. 77  They  proved  that  the  ISO  standard  
recommendations  for  determining  the  long-term  duration  of  prosthetic  zirconia  were 
inadequate 93  and  the  ISO  recommendation  was  revised  according  to  Gremillard’s  
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suggestions. 94  Advances  in  grain  size  reduction  resulted  in  YSZ  ceramics  that  are  more  
resistant  against  LTD,  and  for  this  reason  Sanon  et  al.  recommended  to  increase  the 
ageing  test  up  to  100  h  for  better  observation  of  the  LTD  process.  Our  simulation  was 
extended  to  100  h  following  Sanon’s  proposal. Given  the  very  high  LTD  resistance  that  
nanostructured  YSZ  ceramics  have  shown  compared  to  conventional  microcrystalline 
YSZ  ceramics,  a  new  accelerated  ageing  simulation  protocol  will  be  needed  to 
characterize  any  transformation  and  degradation  which  may  occur  in  these  samples. 95  
We  have  shown  our  3YSZ,  6YSZ,  and  8YSZ  samples  with  AGS  of  147  nm  ±45  nm, 
prepared  using  CAPAD,  satisfy  the  requirements  for  long-term  performance  as  an  optical 
implant.  Indeed,  for  all  the  investigated  samples  the  increase  in  monoclinic  phase  content 
was  below  the  XRD  and  micro-Raman  detection  range,  in  agreement  with  our  previous 
findings. 86  The  ageing  tests  showed  the  ability  of  these  materials  to  withstand  common  
sterilization  treatments  as  well.  LTD  resistant  YSZ  samples  have  been  reported  recently, 
however  they  are  produced  using  the  conventional  zirconia  doped  3  at%  of  Yttria, 90,96   
often  co-doped  with  other  cations. 97 In  these  studies,  the  samples  were  sintered  by 
pressure-less  techniques  with  resulting  grain  sizes  of  hundreds  of  nanometers. 89,96,97  YSZ  
samples  prepared  by  CAPAD  (or  spark  plasma  sintering  (SPS))  with  nanometric  grain 
size  have  also  been  shown  by  others  to  have  very  high  LTD  resistance  and  density. 88,91 It 
should  also  be  noted  that  YSZ  samples  with  similar  grain  size,  mechanical  properties  and 
aging  resistance  have  been  produced  using  more  conventional  multi-step  sintering 
methods. 90  
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Optical  characterization  of  the  pristine  samples  shows  the  optical  transmittance  is 
highly  dependent  on  the  Yttria  dopant  level.  Higher  transmittance  was  found  for  the 
samples  with  higher  Yttria  dopant  content,  although  the  spectral  behaviors  are  similar  for 
the  three  sample  types  (3YSZ,  6YSZ,  and  8YSZ).  This  indicates  the  increase  in  the  Yttria 
content  which  resulted  in  higher  cubic  content  favors  increased  transparency. 63  Decreased  
symmetry  of  the  tetragonal  structure  causes  asymmetric  scattering  in  the  3YSZ  sample 
while  the  more  isotropic  structure  in  the  6YSZ  and  8YSZ  reduces  light  scattering. 63,98 
This  difference  in  crystal  structure  is  the  likely  cause  of  the  differences  in  light 
transmittance.8YSZ  is  the  most  transparent  sample,  allowing  the  transmittance  of  light  in 
a  wider  wavelength  range,  starting  on  610  nm.  The  3YSZ  sample  is  the  least  transparent. 
In  addition,  we  have  shown  the  optical  property  values  have  a  maximum  change  of  3% 
after  100  h  of  the  hydrothermal  treatments  in  wavelength  range  of  500  to  1000  nm  for  all 
the  samples.  This  small  change  is  unlikely  to  be  caused  by  surface  crystal  phase  changes, 
and  may  instead  be  due  to  measurement  error. 
 The  hardness  of  our  nanometric  YSZ  samples,  both  pristine  and  aged,  compare  
well  with  similar  YSZ  materials  reported  in  the  literature. 91,99  A  reduced  yttrium  (~3  
mol%  Yttria)  content  is  generally  associated  with  better  mechanical  properties.  In 
samples  with  higher  Yttria  dopant  contents,  the  hardness  values  are  lower,  whereas,  the 
transparency  is  notably  increased.  The  3YSZ  sample  (tetragonal  structure)  showed  the 
best  mechanical  hardness  and  6YSZ  and  8YSZ  showed  slightly  lower  hardness,  due  to 
higher  Yttria  dopant  content  which  results  in  the  presence  of  a  mixed  tetragonal-cubic 
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structure  (6YSZ)  and  cubic  structure  (8YSZ).  The  changes  in  the  averaged  hardness 
values  after  the  treatments  for  the  3YSZ  and  8YSZ  were  not  significant  (paired  two-tailed 
t  test)  while  a  slight  increase  (<  2%)  was  found  for  the  hardness  of  6YSZ  after  ageing 
treatment.  Increased  hardness  due  to  ageing  an  unexpected  result,  and  may  be  due  to 
measurement  error  of  the  hardness  of  pristine  6YSZ,  which  was  notably  lower  than  the 
hardness  of  the  other  pristine  sample  compositions. 
 The  combination  of  YSZ  nanopowder  and  CAPAD  offers  a  procedure  for  the  
preparation  of  high-density,  transparent  implant  material  suitable  for  the  production  of 
WttB  cranial  prosthesis.  All  the  samples  with  Yttria  dopant  levels  ranging  between  3  and 
8  mol%,  showed  a  strong  resistance  to  LTD  due  to  nanostructuring,  as  demonstrated  by 
extended  ageing  simulations  performed  following  the  ISO  13356:2008.  The  samples 
were  able  to  sustain  tens  of  hours  of  treatments  at  134  °C;  conditions  equivalent  to  many 
decades  of  ageing  in  vivo.  A  higher  Yttria  dopant  level  (8YSZ)  showed  higher 
transmittance  but  presented  slightly  lower  hardness.  Finally,  comparison  of  %monoclinic 
transformation,  optical  transparency,  and  mechanical  properties  of  nc-YSZ  samples  at 
baseline  and  following  up  to  100h  hydrothermal  treatments  shows  our  implants  can 
withstand  the  extended  ageing  treatment. 
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Chapter  3.  Laser  speckle  imaging  of  the  brain  through  the  implant 
Laser  speckle  imaging  (LSI)  is  a  widely  used  imaging  technique  which  is  capable 
of  distinguishing  between  static  and  dynamic  regions  of  a  sample.  Due  to  its  high 
spatiotemporal  resolution,  this  technique  has  proved  useful  for  a  range  of  applications 
such  as  object  velocity  measurements 100 ,  blood  flow  sensing 101 ,  laser  vibrometry 102 , 
surface  roughness  evaluation 103 ,  and  acousto-optic  tomography 104,105 ,  as  well  as  imaging 
blood  flow 101 . 
The  first  application  of  LSI  to  cerebral  blood  flow  imaging 106  used  LSI  spatial  
contrast  analysis 107 .  Subsequently,  LSI  temporal  contrast  was  developed 108,109 ,  which 
allowed  for  reduced  static  noise  and  improved  spatial  resolution  compared  to  LSI  spatial 
contrast  analysis,  at  the  expense  of  temporal  resolution.  In  LSI  temporal  contrast 
imaging,  a  coherent  source  is  directed  onto  a  roughened  surface,  and  the  scattered  light 
produces  a  random  interference  pattern  called  speckle 110,111 .  Movement  of  scattering 
particles  within  the  random  medium  causes  phase  shifts  in  the  scattered  light  and  thus 
changes  the  random  interference  pattern,  producing  temporal  fluctuations  in  the  speckle 
pattern 110,111 .  When  this  speckle  pattern  is  imaged  with  a  camera  of  limited  exposure  time, 
these  temporal  fluctuations  in  the  speckle  pattern  corresponding  to  dynamic  regions  of 
the  sample  appear  smoother  than  the  surrounding  static  regions 112,113 .  The  degree  of 
smoothness  is  measured  as  speckle  contrast,  and  previous  studies  applying  LSI  to 
cerebral  blood  flow  have  shown  that  this  speckle  contrast  correlates  with  blood  flow 
velocity 110,112 . 
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This  improved  method  of  LSI  temporal  contrast  imaging  was  applied  to  intact  rat 
skull 114 ,  but  the  poor  transparency  of  the  skull  resulted  in  limited  spatial  resolution  of  the 
underlying  blood  flow.  Previous  studies  have  addressed  this  challenge  in  animal  models 
by  applying  LSI  through  thinned 115  or  polished 116  skull,  optically  cleared  the  skull 31 ,  or   
replaced  a  portion  of  skull  with  a  transparent  window  made  from  glass  or  PDMS 35,117,118 , 
which  are  powerful  research  techniques  but  which  are  not  appropriate  for  human 
application  as  permanent  cranial  implants  for  patients.  In  Chapter  3,  I  sought  to  expand 
upon  previous  indications  and  show  WttB  implant  allows  for  improved  LSI  spatial 
resolution  of  brain  blood  flow  compared  to  imaging  through  the  native  skull  in  mice. 
Specifically,  I  investigated  the  stability  of  the  WttB  implant  for  LSI  temporal  contrast 
imaging  by  comparing  the  sharpness  of  mouse  cerebral  blood  flow  images  over  28  days.  I 
also  compared  LSI  temporal  contrast  imaging  between  the  WttB  implant  and  native  skull 
in  a  long-term  mouse  at  60  days  post-implantation. 
Methods 
Implant  preparation 
Transparent  nanocrystalline  8  mol%  YO1.5  yttria-stabilized  zirconia  (nc-YSZ) 
implant  samples  were  used  in  this  study  and  fabricated  as  described  in  Chapter  2.  The 
thickness  of  the  resulting  densified  YSZ  discs  were  reduced  from  1  mm  to  ~300  μm  by 
polishing  with  30  μm  diamond  slurry  on  an  automatic  polisher  (Pace  Technologies, 
Tucson,  Arizona  USA).  The  samples  were  then  polished  with  successively  finer  diamond 
and  silica  slurries  ranging  from  6  to  0.2  μm.  Samples  were  sectioned  into  rectangles  of 
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approximately  2.1  x  2.2  mm  using  a  diamond  lapping  saw  (DTQ-5,  WEIYI,  Qingdao, 
China),  followed  by  sonication  in  acetone  and  thorough  rinsing  in  water.  Optical 
transmittance  and  reflectance  spectra  for  the  polished  implants  are  shown  in  Fig ure  3.1 . 
 
Figure  3.1.  Reflectance  and  transmittance  spectra  of  Window  to  the 
Brain  implant. 
 
Animals 
All  experimental  procedures  and  humane  care  of  mice  were  conducted  in 
compliance  with  the  University  of  California,  Riverside  Institutional  Animal  Care  and 
Use  Committee  approval.  The  N  =  4  8-12-week-old  C57Bl/6  male  mice  (Jackson 
Laboratory)  used  in  this  study  were  housed  under  a  12-hour  light  and  12-hour  dark  cycle 
with  ad  libitum  access  to  food  and  water. 
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Surgical  procedures 
Briefly,  mice  were  anesthetized  with  isoflurane  inhalation  (0.2-0.5%),  and  given 
ketamine  and  xylazine  (K/X)  (80/10  mg/kg,  i.p.).  Additional  anesthetic  was  administered 
as  necessary.  Hair  was  removed  from  the  scalp  using  clippers  and  depilatory  cream.  Mice 
were  then  secured  into  stereotaxic  frames  to  immobilize  the  head  for  surgery.  Ophthalmic 
ointment  was  placed  over  the  eyes,  and  the  surgical  site  was  sterilized  with  alternating 
application  of  betadine  and  70%  EtOH  (3  times).  Implants  were  also  sterilized  in  70% 
EtOH. 
A  sagittal  incision  was  made  to  the  left  of  the  midline,  and  the  scalp  retracted  to 
expose  the  skull.  Periosteum  was  removed  from  the  skull,  and  a  craniectomy  was 
performed  with  a  surgical  drill  and  carbide  burr  to  remove  a  square  section  of  skull  over 
the  right  parietal  lobe,  with  dimensions  slightly  larger  than  the  implant.  The  YSZ  implant 
was  placed  within  the  craniectomy  directly  on  the  intact  dura  mater,  and  dental  cement 
was  applied  to  each  of  the  four  corners  of  the  implant  to  prevent  displacement.  Dental 
cement  was  cured  with  UV  light  exposure  for  20  seconds. Figure  3.2(a)  shows  an 
illustration  of  implant  placement  envisioned  in  eventual  human  application,  as  well  as 
implant  placement  used  in  mice  in  this  study. 
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 Figure  3.2.  a)  Illustration  of  the  Window  to  the  Brain  concept  in  human  and  mouse 
skulls,  b)  Schematic  of  the  experimental  imaging  setup,  c)  Schematic  of  the 
craniotomy  location  on  murine  cranium  and  regions  of  interest:  ROI  1,  the  nc-YSZ 
implant  and  ROI  2,  the  left  parietal  bone,  d)  Timeline  for  imaging  procedures. 
 
Imaging  with  LSI  was  conducted  immediately  after  the  cranioplasty  procedure, 
while  the  scalp  was  still  open,  as  well  as  follow-up  imaging  at  14  and  28  days  (for  Mice 
1-3),  or  60  days  (for  Mouse  4)  after  the  implantation  surgery.  For  each  follow-up  imaging 
procedure,  mice  were  anesthetized  as  described  above,  and  the  scalp  was  reopened  to 
expose  the  implant.  Periosteum  overlying  the  implant  (and  skull  for  Mouse  4)  was 
removed,  and  imaging  was  conducted  in  an  identical  manner  to  the  baseline  imaging. 
During  imaging  sessions,  small  amounts  of  saline  was  dropped  onto  the  skull  periodically 
to  prevent  drying.  Following  each  imaging  procedure,  the  scalp  was  closed  with 
continuous  suture,  and  triple  antibiotic  ointment  was  applied  to  the  surgical  site. 
Buprenorphine  was  administered  (0.1  mg/kg,  s.c.)  for  postoperative  pain  control.  Mice 
were  placed  on  a  heating  pad  to  aid  recovery  from  anesthesia.  A  second  buprenorphine 
injection  was  administered  between  4  and  6  hours  after  surgery. 
 
 
30  
Laser  speckle  imaging 
LSI  and  regular  images  of  regions  of  interest  (ROI)  ( Fig ure  3.2(c) )  were  acquired 
using  a  12-bit  CMOS  camera  (DCC1545M,  Thorlabs,  Newton,  NJ,  USA).  For  regular 
images,  a  diffuse  IR  source  was  used  for  illumination.  For  LSI,  an  810  nm  continuous 
wave  NIR  laser  (Vari-Lase  REF946,  Vascular  Solutions,  Morrisville,  NC,  USA)  was  used 
to  illuminate  the  ROI  with  incident  power  of  100  mW  at  a  45°  incidence.  While  most  LSI 
studies  use  visible  wavelengths  for  illumination,  we  chose  810  nm  to  reduce  reflectance 
and  increase  transmittance  through  the  implant  (see Fig ure  3.1 ).  The  810  nm  laser 
intensity  was  homogenized  using  a  diffuser  (ED1-C20-MD,  Thorlabs)  and  was  expanded 
using  a  pair  of  negative-positive  lenses  (KPC043,  −25  mm  EFL  and  KPX094,  100  mm 
EFL,  Newport,  Irvine,  CA,  USA).  Collimated  laser  light  was  shown  onto  the  cortex 
through  the  WttB  implant  (i.e.  ROI  1  in  Mice  1-3)  or  through  both  skull  and  implant  (i.e. 
ROI  1  and  ROI  2  in  Mouse  4).  A  sequence  of  laser  speckle  images  reflected  from  each 
illuminated  region  was  captured  by  the  CMOS  camera,  which  was  focused  0.2  mm  below 
the  cortical  surface  using  a  10X  zoom  microscope  (MLH-10X,  152.4  mm  WD, 
Computar,  Torrance,  CA,  USA).  For  each  ROI,  a  sequence  of  n  =  100  images  were 
captured  at  each  of  four  different  exposure  times  (1,  2,  6,  and  10  ms)  at  a  speed  of  14 
frames  per  second.  The  aperture  and  magnification  of  the  zoom  microscope  were 
carefully  chosen  to  ensure  that  the  speckle  size  at  the  image  plane  was  approximate  to  the 
area  of  a  single  pixel  in  the  CMOS  chip 108,114 .  A  schematic  of  the  LSI  system  is  shown  in 
Fig ure  3.2(b) . 
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Experimental  design 
In  this  study,  we  conducted  two  separate  experiments.  Experiment  1  was 
conducted  using  mice  1-3,  with  LSI  through  the  implant  (i.e.  ROI  1)  at  baseline 
immediately  following  implantation,  and  again  after  14  and  28  days  post-implantation.  In 
Experiment  2,  the  LSI  field  of  view  was  expanded  to  include  both  the  implant  (ROI  1)  as 
well  as  native  skull  (ROI  2)  in  Mouse  4  at  60  days  post-implantation.  For  both 
experiments,  LSI  imaging  was  conducted  at  4  different  exposure  times.  A  timeline  of 
imaging  procedures  for  the  two  experiments  is  shown  in  Fig ure  3.2(d) . 
Image  processing  and  data  analysis 
The  contrast-resolved  LSI  images  were  constructed  based  on  temporal  statistical 
analysis  of  laser  speckle  which  has  been  proven  to  preserve  spatial  resolution 108,114 . 
Experimental  results  have  indicated  that  temporal  speckle  contrast  analysis  could 
expressively  suppress  the  effect  of  the  static  laser  speckle  pattern  formed  by  the 
stationary  superficial  reflection  and  scattering  tissue  on  the  visualization  of  blood 
flow 108,114 .  Suppressing  this  effect  makes  temporal  contrast  analysis  an  ideal  method  for 
imaging  cerebral  blood  flow  through  skull  and  the  transparent  nc-YSZ  implant.  The 
temporal  contrast,  Kt ,  of  each  image  pixel  in  the  time  sequence  was  calculated  using  108 , 
 
(3.1) 
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where  Ix,y(n)  is  the  intensity  at  pixel  (x,y)  in  the  nth  image,  N  is  the  number  of  images 
acquired,  and  Ix,y  is  the  mean  value  of  intensity  at  pixel  (x,y)  over  the  N  images.  We 
assessed  the  quality  of  the  speckle  contrast  images  over  time  in  terms  of  signal  to  noise 
ratio  (SNR)  and  vessel  sharpness.  To  quantify  signal  to  noise  ratio  for  each  exposure  time 
and  time  point,  the  contrast  intensity  profile  along  a  vertical  line  (across  the  blood 
vessels)  was  considered.  The  profile  lines  were  chosen  for  each  mouse  such  that  3  to  4 
vessels  were  intersected,  and  remained  the  same  between  the  time  points  and  the 
exposure  times.  Figure  3.3(b)  shows  an  example  of  the  contrast  intensity  profile  for  6  ms 
exposure  time  at  day  0,  14  and  28  for  Mouse  3.  Equation  (3.2)  shows  how  SNR  values 
were  calculated  for  each  exposure  time  and  time  point,  
 
 (3.2) 
 
where  ΔK  is  the  depth  of  the  vessel  peak  from  the  baseline  (mean  noise)  and  σKn  is  the 
standard  deviation  of  the  noise.  A  visual  example  of  ΔK  and  σKn  are  shown  in  Figure 
3.3(b).  The  SNR  values  were  averaged  over  the  mice  (1,  2,  and  3)  and  standard  errors 
were  calculated.  The  optimum  SNR  between  the  exposure  times  in  each  time  point  was 
chosen  for  the  contrast  images  sharpness  comparison.  As  an  indicator  of  resolution,  we 
compared  the  sharpness  of  the  vessel  edges  in  images  by  calculating  fall  distance  (the 
number  of  pixels)  of  the  edge  of  the  vessel  to  go  from  10%  to  90%  of  ΔK  value  were 
calculated.  A  shorter  fall  distance  corresponds  to  greater  sharpness.  The  same  sampled 
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contrast  intensity  profiles  were  considered  for  the  fall  distance  calculation.  Figure  3.3(b) 
shows  an  example  trace  and  10–90%  fall  distance  measurement.  In  order  to  evaluate  the 
change  in  sharpness  over  the  time  points  in  Experiment  1,  relative  change  in  fall  distance 
over  the  time  points  day  14  and  day  28  compared  to  day  0  baseline  for  each  animal  and 
vessel  were  evaluated  using  Eq.  (3.3). 
  
(3.3) 
 
To  compare  the  blood  vessel  images  through-skull  and  through-implant  in 
Experiment  2,  absolute  fall  distances  with  respect  to  the  vessels  size  (FWHM)  were 
determined.  FWHM  of  the  vessels  in  profiles  were  taken  as  the  vessel  diameter  (Figure 
3.3(b)).  
Results 
LSI  image  quality  over  time  (Experiment  1) 
The  results  from  Experiment  1  are  shown  in  Figures  3.3  and  3.4.  Figure  3.3(a) 
shows  regular  images  and  LSI  temporal  contrast  images  at  each  of  the  4  exposure  times, 
for  days  0,  14  and  28  from  Mouse  3  (data  for  Mice  1-2  not  shown).  In  the  regular  images, 
some  tissue  regrowth  is  visible  at  the  implant  edges  at  14  and  28  days.  It  should  also  be 
noted  that  at  day  0,  blood  flow  is  expected  to  be  altered  in  response  to  the  invasive 
cranioplasty  surgery  (e.g.  due  to  potential  reactive  hyperemia  (increased  blood  flow), 
changes  in  respiration,  etc.).  Due  to  these  differences  in  the  mouse  biology  and 
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physiology  at  different  imaging  time  points,  we  sought  to  determine  the  optimal  exposure 
time  for  LSI  imaging  at  each  time  point,  so  that  we  could  compare  the  images  of  highest 
SNR  that  could  be  acquired  at  each  time  point.  
 
Figure  3.3 a)  Regular  images  and  LSI  images  for  exposure  times  of  1,  2,  6,  and  10 
ms,  at  0,  14  and  28  days  post-surgery  from  Mouse  3  (scale  bars  =  1  mm).  b)  Contrast 
intensity  profiles  of  lines  across  the  images  (shown  as  a  dashed  line  in  panel  a)  at  0, 
14  and  28  days  post-surgery  from  Mouse  3.  The  arrows  in  a)  show  the  vessels  that  are 
intersected  by  the  profile  lines  shown  in  b),  labeled  as  V1  through  V4  in  day  0  image 
and  profile  (V4  arrow  was  not  shown  in  day  14  and  day  28  since  the  microvessel  is 
not  visible).  The  inset  in  b)  shows  how  noise  parameters,  |ΔK|,  FWHM  and  fall 
distance  are  determined  from  the  line  profiles. 
 
Line  intensity  profiles  like  the  example  shown  in Fig ure  3.3(b)  were  analyzed  for 
all  exposure  times  and  imaging  time  points  in  Mice  1-3.  From  these  intensity  profiles, 
peak  intensity  and  noise  were  determined  (as  described  in  the  Methods  section  and 
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illustrated  in  the  inset  of Fig ure  3.3(b) ),  and  signal-to-noise  ratio  (SNR)  was  calculated. 
Data  for  each  time  point  and  exposure  time  was  averaged  between  the  three  mice,  and  is 
shown  in Fig ure  3.4(a) .  As  shown  in  the  figure,  an  exposure  time  of  6  ms  gave  the 
highest  SNR  at  0  and  28  days,  while  10  ms  exposure  time  gave  a  higher  SNR  at  14  days. 
Next,  using  the  9  LSI  temporal  contrast  images  corresponding  to  these  optimal 
exposure  times  for  days  0,  14  and  28  for  Mice  1-3,  we  sought  to  compare  the  sharpness 
(i.e.  fall  distance)  of  the  vessels  in  the  images  to  determine  if  the  images  were  becoming 
blurred  and  losing  resolution  over  time  since  implantation.  The  relative  change  in  fall 
distance  between  days  14  and  28  compared  to  day  0  baseline  are  shown  in Fig ure  3.4(b) , 
and  was  below  a  13%  increase  for  all  vessels  analyzed.  On  average,  relative  fall  distance 
increased  by  6.56%  ±  1.03%  by  day  14,  and  7.69%  ±  1.2%  by  day  28  compared  to  day  0. 
 
Figure  3.4.  a)  SNR  for  different  exposure  times  and  imaging  time  points  (mean  and 
standard  error)  and  b)  Relative  change  in  fall  distance  between  days  14  and  28  vs  day 
0  for  3  vessels  each  of  Mice  1-3  (dashed  lines  represent  mean  change  i5n  fall  distance 
for  all  9  vessels). 
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LSI  image  quality  through  skull  vs.  chronic  implant  (Experiment  2) 
As  the  goal  of  the  WttB  implant  is  to  provide  long-term  optical  access  to  the  brain 
for  imaging  techniques  such  as  LSI,  we  sought  to  compare  LSI  imaging  through  the 
native  skull  with  imaging  through  a  chronic  implant  which  had  been  in  the  body  long 
term.  Thus,  in  Experiment  2,  Mouse  4  was  imaged  with  LSI  60  days  post-implantation. 
To  make  a  direct  comparison  between  the  implant  and  skull,  the  LSI  field  of  view  was 
expanded  to  include  both  ROI  1  (the  implant  over  the  right  parietal  lobe)  and  ROI  2 
(corresponding  region  of  skull  over  the  left  parietal  lobe)  in  the  same  image. Figure  3.5(a) 
shows  the  LSI  temporal  contrast  images  for  exposure  times  of  1,  2,  6  and  10  ms. 
Unlike  Experiment  1,  where  a  given  field  of  view  was  compared  with  itself  over 
time,  Experiment  2  compares  two  separate  regions  of  the  brain  with  different  vessels. 
Thus,  for  this  second  experiment,  3  line  profiles  with  taken  for  the  implant  and  for  the 
corresponding  region  of  skull.  To  avoid  selection  bias,  the  location  of  these  line  profiles 
were  chosen  arbitrarily  at  the  ROI  mid-  and  quarter-points,  as  depicted  in  the  regular 
image  in Fig ure  3.5(b) .  As  an  example, Fig ure  3.5(c)  shows  the  intensity  profiles  from 
the  midline  of  both  ROI  1  and  ROI  2  for  exposure  time  6  ms. 
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 Figure  3.5.  a)  LSI  temporal  contrast  images  for  4  exposure  times  in  Mouse  4.  The 
left  side  of  each  image  is  the  WttB  implant  (ROI  1),  and  ROI  2  is  the  corresponding 
region  of  skull  on  the  right  side  of  each  image.  b)  Regular  image  of  implant, 
showing  the  arbitrary  locations  where  line  profiles  were  taken.  c)  Example  contrast 
intensity  profiles  along  the  midline  of  ROI  1  and  2  for  exposure  time  6  ms.  The 
arrows  in  a)  and  c)  show  the  vessels  that  are  intersected  by  the  midline  intensity 
profiles.  Scale  bars  =  1  mm. 
 
 
 
 
 
 
 
 
 
 
 
38  
Using  the  same  analysis  methods  described  in  Experiment  1,  we  calculated  the 
SNR  from  each  line  profile  in  ROI  1  and  ROI  2  for  each  exposure  time.  The  mean  SNR 
for  each  exposure  time  is  shown  in Fig ure  3.6(a) .  The  6  ms  exposure  time  LSI  temporal 
contrast  image  resulted  in  the  highest  SNR  for  both  implant  and  skull,  and  thus  we  used 
this  image  to  compare  the  SNR  and  sharpness  of  detected  vessels  by  LSI  between  native 
skull  and  a  long-term  WttB  implant.  By  the  same  method  used  in  Experiment  1,  we 
analyzed  the  3  line  profiles  across  the  WttB  implant  and  3  line  profiles  across  the  skull  to 
determine  the  fall  distance  and  SNR  for  each  vessel.  Additionally,  the  full-width  half-max 
(FWHM)  of  each  vessel  in  the  line  profiles  were  taken  as  vessel  diameter 62 . Figure  3.6(b) 
shows  a  plot  of  all  vessels  intersected  by  the  6  profile  lines,  with  SNR  plotted  against 
FWHM  (i.e.  vessel  diameter).  A  plot  of  all  vessels  intersected  by  the  6  profile  lines,  with 
absolute  fall  distance  (i.e.  vessel  sharpness)  plotted  against  FWHM  (i.e.  vessel  diameter) 
is  shown  in  Fig ure  3.6(c ). 
 
Figure  3.6.  a)  Mean  SNR  of  contrast  intensity  along  arbitrary  line  profiles  on  the 
implant  and  skull  for  4  separate  exposure  times  (error  bars  represent  standard  error),  b) 
and  c)  SNR  and  sharpness  (respectively)  vs  FWHM  for  all  vessels  intersected  by 
arbitrary  line  profiles  on  the  implant  and  skull  for  the  LSI  temporal  contrast  image 
acquired  with  6  ms  exposure  time. 
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Discussion 
As  the  goal  of  the  WttB  implant  is  to  provide  this  access  long-term,  it  is  important 
that  the  optical  access  is  not  lost  over  time.  In  Chapter  3,  I  assessed  LSI  temporal  contrast 
imaging  quality  (i.e.  sharpness)  of  cerebral  blood  vessels  imaged  through  the  implant  up 
to  60  days  post-implantation. 
In  LSI  temporal  contrast  imaging,  the  exposure  time  of  the  camera  can  have  a 
large  effect  on  image  quality.  As  exposure  time  increases,  both  the  contrast  intensity  and 
noise  of  the  image  increase 119 .  While  the  contrast  plateaus  after  some  threshold,  noise 
continues  to  increase  with  exposure  time.  Several  sources  of  noise  contribute  to  the 
measured  noise,  including  physiological  noise,  hardware  noise,  environmental  noise,  and 
noise  due  to  statistical  uncertainties.  The  total  noise  of  the  speckle  contrast  signal  is  a 
combination  of  all  of  these  sources  and  the  relative  contributions  of  each  of  these  exhibit 
different  characteristics  with  respect  to  the  exposure  time 119 .  However,  in  our 
experiments,  the  physiologic  noise  (including  noise  due  to  implantation  surgery)  is  the 
dominant  source  because  it  is  the  only  one  that  is  changing  considerably  over  time. 
Physiologic  noise  arises  from  motion  of  the  tissue  such  as  heartbeat  or 
respiration-induced  pulsatile  motion  of  the  exposed  cortex,  baseline  fluctuations  in  the 
cerebral  blood  flow,  and  possibly  tissue  regrowth  and  revascularization  following 
implantation.  This  motion  and  blood  flow  fluctuations  introduce  additional  velocity 
components  to  the  measured  signal  and  therefore  cause  speckle  contrast  fluctuations. 
Since  the  physiological  noises  will  be  different  on  different  days,  exposure  time  should 
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be  optimized  during  each  imaging  session.  To  determine  the  optimal  exposure  time  in  this 
study,  we  compared  the  SNR  of  images  taken  at  exposure  times  of  1,  2,  6,  and  10  ms 
( Figure  3.4(a) , Figure  3.6(a) ),  and  each  imaging  session  proceeded  with  the  exposure 
time  that  maximized  SNR.  Indeed,  our  results  found  that  the  optimal  exposure  time 
differed  between  the  imaging  time  points  in  Experiment  1,  with  maximum  SNR  for 
exposure  time  of  6  ms  at  days  0  and  28,  and  10  ms  at  day  14.  This  may  be  explained  by 
the  differences  in  physiology  between  these  time  points.  At  day  0,  altered  blood  flow  due 
to  the  implantation  surgery  is  expected,  and  elevated  blood  flow  could  give  high  contrast 
to  the  vessels.  Thus,  a  lower  exposure  time  (6  ms)  can  provide  sufficient  contrast  of  the 
blood  flow,  while  keeping  noise  low.  By  day  14,  flow  would  no  longer  be  modified  in 
response  to  the  surgery,  and  thus  a  higher  exposure  time  (10  ms)  may  be  needed  to 
increase  contrast  in  the  images.  At  time  points  beyond  14  days,  flow  remains  low 
compared  to  day  0,  but  noise  may  increase  due  to  healing  processes  (tissue  regrowth, 
revascularization,  etc.),  and  thus  a  shorter  exposure  time  (6  ms)  may  provide  the  best 
compromise  between  increased  contrast  and  reduced  noise.  It  should  be  noted,  however, 
that  the  modification  of  blood  flow  at  the  different  time  points,  as  evidenced  by  the 
different  optimal  exposure  times,  may  also  be  due  to  several  other  confounding  factors. 
Anesthetic  agents  (including  isoflurane  and  ketamine  used  in  this  study)  are  known  to 
modulate  cerebral  blood  flow,  and  the  concentration  of  these  drugs  in  the  blood  stream 
was  not  kept  constant  over  the  imaging  sessions.  Respiration  can  cause  noise  in  LSI,  and 
its  rate,  along  with  arterial  blood  gas  levels,  can  significantly  alter  blood  flow.  These 
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variables,  in  addition  to  the  small  sample  size  used  in  this  study,  make  it  difficult  to 
attribute  the  observed  differences  in  blood  flow  between  the  time  points  to  a  particular 
cause. 
Image  resolution  (i.e.  sharpness)  was  found  to  decrease  by  up  to  13%  over  the  28 
days  compared  to  day  0  baseline  in  the  9  vessels  analyzed  from  Mice  1-3  ( Figure  3.4(b) ). 
The  relative  increases  in  average  fall  distance  between  day  14  and  day  28  compared  to 
day  0  were  6.56%  ±  1.03%  and  7.69%  ±  1.2%,  respectively.  It  should  be  noted  that  while 
day  0  is  considered  as  the  baseline  for  comparison,  it  does  not  represent  an  unperturbed 
state  of  normal  cerebral  blood  flow.  It  is  likely  that  blood  flow  was  altered  in  response  to 
the  invasive  cranioplasty  surgery,  and  thus  the  higher  SNR  and  sharpness  of  the  day  0 
images  compared  with  days  14  and  28  may  be  due  in  part  to  an  elevated  signal  at  day  0, 
rather  than  a  loss  of  signal  at  days  14  and  28.  SNR  and  sharpness  stayed  more  stable 
between  14  and  28  days,  consistent  with  this  hypothesis.  Additionally,  new  microvessels 
which  were  not  visible  in  day  0  are  visible  at  these  later  time  points,  which  suggests 
revascularization  may  be  occurring  near  the  implant  surface.  Together,  these  results 
appear  to  indicate  that  image  quality  remains  high  up  to  28  days  post-implantation,  but 
additional  longer  time  points  are  needed  to  confirm  this  is  the  case.  In  Experiment  2,  a 
day  60  time  point  shows  that  SNR  is  similar  to  the  SNRs  obtained  at  days  14  and  28  in 
Experiment  1  (SNR  between  3  to  4  in  both Figure  3.4(a)  and Figure  3.6(a) ),  and 
microvessels  are  clearly  visible  at  this  later  time  point  ( Figure  3.5(a) ). 
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Comparing  imaging  through  the  skull  and  a  long-term  (60  days)  implant  ( Figure 
3.5(a) ),  the  skull  had  a  higher  SNR  for  lower  exposure  times  (1  and  2  ms),  and  the 
implant  SNR  was  higher  at  longer  exposure  times  (6  and  10  ms)  ( Figure  3.6(a) ).  The 
higher  SNR  of  the  through-skull  images  compared  with  implant  at  short  exposure  times 
may  be  explained  by  the  natural  filtering-out  of  smaller  vessels  imaged  through  the  skull. 
Imaging  through  the  window,  on  the  other  hand,  resolves  small  vessels  which  are  more 
sensitive  to  exposure  time.  At  low  exposure  time,  the  contrast  of  these  small  vessels  is 
very  low,  contributing  to  the  lower  SNR  through  the  window  compared  to  skull. 
Exposure  time  of  6  ms  gave  the  highest  SNR  for  both  skull  and  implant  and  was  used  for 
comparing  SNR  and  sharpness  of  vessels  imaged  beneath  each.  Because  this  comparison 
was  made  between  two  different  spatial  regions  of  the  brain,  different  vessels  of  varying 
diameter  were  compared.  Thus,  SNR  and  sharpness  of  vessels  (fall  distance)  are  plotted 
against  the  vessel  diameter  (FWHM  of  vessels  in  intensity  profiles).  As  mentioned  earlier 
a  number  of  small  vessels,  associated  with  lower  blood  flow  and  accordingly  SNR,  were 
detected  through  the  implant  which  were  naturally  filtered-out  by  the  skull  ( Figure 
3.6(b) ).  These  detected  small  vessels  decreased  the  averaged  SNR  shown  in Figure 
3.6(a) .  In Figure  3.6(c) ,  interestingly,  the  data  from  the  skull  and  implant  fell  into 
separate  clusters,  with  vessels  imaged  through  the  implant  having  smaller  FWHM  and 
shorter  fall  distances,  while  vessels  imaged  through  the  skull  have  larger  FWHM  and 
higher  fall  distances.  This  data  shows  that  vessels  imaged  through  the  implant  appear 
smaller  in  diameter  and  have  sharper  borders  compared  to  those  imaged  through  the 
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skull.  As  the  size  of  vessels  and  velocity  of  blood  flow  is  not  expected  to  differ  on 
average  between  the  two  hemispheres  of  the  mouse  brain,  the  apparent  increase  in  vessel 
diameter  imaged  through  the  skull  vs  implant  is  likely  due  to  blurring  of  the  image 
through  the  skull.  In  general,  the  light  transmission  to  the  brain  and  reflection  from  the 
brain  are  lower  in  the  through-skull  image.  Additionally,  the  skull  scattering  disorders  the 
speckle  pattern  that  was  created  by  the  brain  hemodynamics,  making  a  less  accurate 
speckle  pattern.  Both  of  the  defects  are  caused  by  skull  and  the  skull  texture  is  not 
homogeneous,  making  image  correction  or  enhancement  very  complex 114 .  The  reduction 
in  border  sharpness  of  the  vessels  imaged  through  the  skull  vs  implant  is  consistent  with 
this  explanation,  and  the  blurred  nature  of  the  through-skull  image  compared  to  the 
through-implant  image  is  visually  apparent  in Figure  3.5(a) .  It  should  also  be  noted  that 
while  the  SNR  and  sharpness  of  the  through-implant  images  are  an  improvement  over  the 
through-skull  images,  the  mouse  skull  is  inherently  transparent  itself 114 ,  which  is  not  the 
case  in  larger  animals  or  humans. 
LSI  temporal  contrast  imaging  has  become  a  useful  tool  for  brain  blood  flow 
applications  as  the  images  it  produces  contain  functional  information  (i.e.  relative  blood 
velocity)  in  addition  to  showing  structure  of  the  vessel  networks. Figure  3.7  contains  a 
color  map  version  of  the  6  ms  LSI  image  from  Mouse  4  ( Figure  3.5(a) ),  where  minimum 
relative  velocity  (i.e.  static  regions)  appears  blue  and  maximum  relative  velocity  (i.e. 
maximum  blood  flow  velocity)  appears  red.  As  seen  in Figure  3.7 ,  much  more  precise 
velocity  information,  particularly  of  microvessels,  can  be  detected  through  the  implant, 
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while  the  reduced  sharpness  of  the  vessels  imaged  through  skull  obscures  precise  flow 
determinations.  Imaging  microvessels  (usually  involving  small  arteries  of  less  than 
150 μm  in  diameter,  arterioles,  capillaries,  and  venules 120,121 )  is  important  for  many 
applications,  as  microcirculation  plays  a  critical  role  in  physiological  processes  such  as 
tissue  oxygenation  and  nutritional  exchange.  Monitoring  the  spatio-temporal 
characteristics  of  microcirculation  is  crucial  for  studying  the  normal  and 
pathophysiologic  conditions  of  tissue  metabolism.  It  is  also  useful  for  assessing 
microcirculatory  dysfunction  due  to  disease  conditions  such  as  type  2  diabetes,  peripheral 
vascular  disease  (PVD),  atherosclerotic  coronary  artery  disease,  obesity,  heart  failure, 
Alzheimer’s,  schizophrenia  and  hypertension,  among  others.  In  addition,  quantification  of 
dynamic  blood  flow,  angiogenesis,  and  vessel  density  are  critical  for  monitoring  the 
progression  of  wound  healing.  Although  high  resolution  vascular  network  mapping  is 
possible  using  imaging  modalities  such  as  computed  tomography  (CT),  these  approaches 
require  injection  of  contrast  agents  and  pose  disadvantages  such  as  radiation  exposure. 
Existing  non-invasive  methodologies  (including  LSI  through  skull)  are  inadequate  to 
study  blood  flow  at  microvessel  resolution 122 .  Windows  such  as  the  WttB  implant  are  thus 
important  tools  for  research,  and  in  the  case  of  the  WttB  implant,  can  become  important 
enablers  of  clinical  diagnostics  and  therapy  involving  cerebral  microvessels. 
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 Figure  3.7.  Relative  blood  flow  velocity  in  the  6  ms 
exposure  time  LSI  temporal  contrast  image  from 
Mouse  4.  Scale  bar  =  1  mm. 
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Chapter  4.  Optical  Access  to  Arteriovenous  Cerebral  Microcirculation 
Background 
Microcirculation  plays  a  critical  role  in  the  physiological  processes  of  tissue 
oxygenation  and  nutrient  exchange  within  the  brain 11 .  In  recent  years,  the  recognition  that 
microcirculation  is  also  involved  in  a  number  of  pathophysiologic  processes  has  further 
increased  interest  in  its  study 11 .  Microcirculation  can  be  measured  in  several  ways, 
including  (but  not  limited  to)  morphological  imaging  methods  to  measure  vessel  density, 
perfusion  rate,  vessel  diameter,  and  dynamic  measurements  of  microcirculatory  blood 
flow  velocity  and  blood  cell  concentration 11 ,  as  well  as  functional  imaging  methods  to 
provide  information  on  blood  oxygenation,  changes  in  metabolism,  regional  chemical 
composition,  and  so  on 12 . 
In  addition  to  information  on  vessel  geometry  and  flow  characteristics,  distinction 
between  arteries  and  veins  is  of  great  clinical  importance.  The  ability  to  independently 
render  veins  and  arteries  on  blood  perfusion  maps  has  a  variety  of  potential  applications 
in  the  head,  neck,  lungs,  heart,  abdomen,  and  lower  extremities,  and  most  critically  in  the 
cerebrovascular  system  including  brain  arteriovenous  malformation  and  dural 
arteriovenous  fistulas 123 ,  cerebral  hemorrhage,  stroke,  and  aneurysm 124 . 
In  this  chapter,  we  utilized  the  wide  light  transmission  range  of  WttB  implant  for  a 
dual-modal  imaging  system  of  multispectral  reflectance  imaging  (MSRI)  and  LSI.  MSRI 
is  a  simple  and  low‐cost  method  capable  of  distinguishing  between  veins  and  arteries 
based  on  differences  in  the  optical  absorption  of  oxyhemoglobin  and  deoxyhemoglobin. 
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This  method  has  been  developed  in  visible  and  near‐infrared  (NIR)  wavelength 
range 125,126 .  This  method  involves  a  white  light  source,  optical  filters,  and  a  camera,  and 
can  easily  be  coupled  with  LSI 124 .  Indeed,  a  single  instrument  combining  laser  speckle 
flowmetry  and  MSRI  has  been  demonstrated  in  a  rodent  thinned  skull  model 126  for  
simultaneous  relative  cerebral  blood  flow  and  hemoglobin  oxygen  saturation  changes 
during  ischemia 127  and  functional  activation 128 .  A  thinned  skull  preparation  was  necessary  
due  to  the  high  scattering  and  absorption  of  the  skull  in  the  visible  and  NIR  range,  which 
limits  the  accessibility  of  MSRI  wavelengths  for  detecting  hemoglobin  oxygenation 
information.  When  MSRI  has  been  applied  through  the  intact  skull,  only  skull  regions 
and  not  individual  microvessels  are  visible.  Likewise,  in  our  own  prior  studies  we  have 
found  that  imaging  through  intact  skull  with  LSI  limits  the  size  of  vessels  that  can  be 
detected,  and  precludes  imaging  of  the  microcirculation.  Moreover,  the  absorption  and 
reflectance  features  of  the  inhomogeneous  cranial  bone  overlap  with  those  of  brain  tissue, 
and  the  skull  also  has  its  own  vessels.  Together,  these  factors  decrease  the  accuracy  and 
reliability  of  the  data. 
Window  to  the  Brain  implant  made  of  Yttria‐stabilized  zirconia  (YSZ)  represents 
an  attractive  alternative.  Additional  benefits  of  this  material  over  imaging  through  skull 
include  its  stable  optical  behavior,  as  proven  in  Chapter  3,  and  lack  of  optical  absorption 
by  water  and  hemoglobin  (Figure  3.1).  We  envision  this  implant  as  a  potential  future 
optical  access  to  the  brain  allowing  for  real‐time  monitoring  of  arteriovenous  cerebral 
blood  flow  (Figure  4.1). 
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In  this  present  study,  we  performed  cerebral  arteriovenous  microcirculation 
imaging  by  combining  MSRI  and  LSI  techniques.  This  method  was  applied  in  a  mouse 
model,  first  through  the  closed  skull,  then  to  the  dura  mater  and  brain  directly  after  a 
craniectomy  was  performed  to  remove  a  piece  of  skull,  and  finally  through  the  WttB 
implant  after  the  implant  was  placed  within  the  craniectomy  on  the  dura  mater.  The 
imaging  obtained  through  the  WttB  implant  and  through  the  skull  were  compared  to  the 
imaging  obtained  through  the  open  skull,  which  served  as  a  reference.  The  goal  of  this 
study  was  to  assess  the  improvement  in  brain  imaging  with  MSRI‐LSI  when  captured 
through  the  WttB  implant  versus  imaging  through  the  skull. 
 
Figure  4.1.  (a,  b)  Illustration  of  the  Window  to  the  Brain  concept  as  envisioned  for  future 
human  application,  to  allow  for  real‐time  monitoring  of  arteriovenous  cerebral  blood 
flow.  (c)  Transmittance  spectra  of  Window  to  the  Brain  implant. 
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Methods 
Animals 
All  experimental  procedures  and  humane  care  of  mice  were  conducted  in 
compliance  with  the  University  of  California,  Riverside  Institutional  Animal  Care  and 
Use  Committee  approval.  The  N = 1  1 2‐week‐old  C57Bl/6  male  mouse  (Jackson 
Laboratory,  Bar  Harbor,  ME)  used  in  this  study  was  housed  under  a  12‐hour  light  and 
12‐hour  dark  cycle  with  ad  libitum  access  to  food  and  water. 
Surgical  Procedures 
The  mouse  was  implanted  with  a  WttB  implant  as  described  previously  in  Chapter 
3.  Imaging  was  conducted  with  the  scalp  open,  before  craniectomy  with  the  skull  closed 
(condition  1),  immediately  after  craniectomy  with  the  skull  open  (condition  2),  and  after 
the  WttB  implantation  (condition  3). 
 
Figure  4.2. Schematic  of  the  experimental  imaging  setup  including  laser  speckle  imaging 
(LSI)  and  multispectral  reflectance  imaging  (MSRI).  The  inset  shows  a  schematic  of  the 
imaging  fields  of  view  on  murine  cranium,  with  the  blue  tetragonals  representing  the 
imaging  field. 
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MSRI  and  LSI 
MSRI  was  performed  by  optically  filtering  a  white‐light  source  (MI‐150; 
Dolan‐Jenner,  Boxborough,  MA).  Optical  bandpass  filters  mounted  on  a  fast‐change  filter 
wheel  (FW103H;  Thorlabs,  Newton,  NJ)  were  used  to  isolate  different  spectral 
components  and  provided  a  six‐wavelength  (560,  570,  580,  590,  600,  and  610 nm) 
multispectral  dataset,  as  shown  in  Figure  4.2.  For  LSI,  an  810 nm  continuous  wave  NIR 
laser  (DL808‐7W0‐O;  CrystaLaser,  Reno,  NV)  was  used  to  illuminate  the  region  of 
interest  with  incident  power  of  100 mW  at  a  45°  incidence.  While  most  LSI  studies  use 
visible  wavelengths  for  illumination,  we  chose  810 nm  to  reduce  reflectance  and  increase 
transmittance  through  the  WttB  implant  (see  Figure  3.1).  The  810 nm  laser  intensity  was 
homogenized  using  a  diffuser  (ED1‐C20‐MD;  Thorlabs)  and  was  expanded  using  a  pair 
of  negative‐positive  lenses  (KPC043,  −25 mm  EFL  and  KPX094,  100 mm  EFL; 
Newport,  Irvine,  CA).  Multispectral  incoherent  light  and  diffused  laser  light  were 
sequentially  shown  onto  the  closed  skull  (i.e.,  condition  1),  onto  the  dura  mater  and 
cortex  after  craniectomy  (i.e.,  condition  2)  and  through  the  WttB  implant  (i.e.,  condition 
3).  The  reflected  light  from  the  illuminated  region  was  captured  by  a  12‐bit 
complementary  metal‐oxide‐semiconductor  (CMOS)  camera  (DCC1545M;  Thorlabs), 
which  was  focused  at  the  cortical  surface  using  a  ×10  zoom  microscope  (MLH‐10X, 
152.4 mm  WD;  Computar,  Torrance,  CA).  For  each  imaging  condition,  a  sequence  of  six 
multispectral  images  and  100  laser  speckle  images  were  captured.  Laser  speckle  images 
were  acquired  at  exposure  times  of  6 ms  (per  our  previous  report  on  optimized  LSI 
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exposure  time 24 )  at  a  speed  of  14  frames  per  second.  The  aperture  and  magnification  of 
the  zoom  microscope  were  carefully  chosen  to  ensure  that  the  speckle  size  at  the  image 
plane  was  approximate  to  the  area  of  a  two  pixel  in  the  CMOS  chip.  A  schematic  of  the 
imaging  system  is  shown  in  Figure  4.2.  In  image  processing,  each  camera  frame  was 
registered  to  one  another  to  ensure  appropriate  spatial  alignment  over  the  MSRI  and  LSI 
images.  In  MSRI,  normalizing  each  individual  wavelength  to  its  corresponding  white 
reference  (WS‐1;  Ocean  Optics,  Oxford,  UK)  image  compensated  for  variations  in  the 
illumination.  The  white  reference  images  were  captured  through  the  WttB  implant  in 
condition  3. 
Vein‐Artery  Separation  Using  MSRI 
The  MSRI  approach  relies  on  the  distinctive  absorption  spectra  of  oxy‐  and 
deoxyhemoglobin  (HbO2  and  HbR).  The  hemoglobin  in  blood  is  the  most  significant 
absorber  in  the  brain  at  visible  and  NIR  wavelengths.  HbR  and  HbO2  have  different 
absorption  spectra,  and  thus  based  on  the  Beer‐Lambert  law 129 ,  measurements  with 
different  wavelengths  of  light  can  produce  images  that  are  preferentially  sensitive  to 
difference  in  the  concentration  of  HbO2  and  HbR.  At  isobestic  points,  the  HbR  and 
HbO2  optical  extinction  coefficient  are  similar  (568  and  587 nm).  At  560,  600,  and 
610 nm,  areas  with  higher  level  of  deoxy‐hemoglobin  C  (e.g.,  the  veins)  leads  to  more 
optical  extinction  and  thus  makes  the  corresponding  area  darker  (i.e.,  lower  intensity 
values  in  the  images),  and  therefore  we  can  provide  artery‐vein  separation.  In  this  case, 
we  assume  that  scattering  in  the  brain  does  not  change  significantly  during  the 
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experiment.  To  separate  the  vein  and  arteries  in  MSRI  images,  the  vasculature  branches 
were  detected  and  mapped  manually  for  seven  branches  in  regular  white‐light  images 
(Figure  4.3(a)).  Each  vasculature  branch  was  labeled  by  a  number.  To  obtain  the  mean 
intensity  of  a  branch,  10  samples  of  intensity  (4 × 4  pixels)  were  extracted  and  averaged 
from  each  branch  and  called  vessel  branch  intensity.  The  sample  intensities  of  each 
branch  were  evenly  distributed  along  the  midline  of  the  main  vessel  of  the  branch  (Figure 
4.3(a)).  The  samples  locations  were  kept  constant  for  each  vasculature  branch  over  the 
multispectral  images.  Then,  normalized  extinction  was  obtained  over  the  wavelengths  by 
calculating  the  difference  in  intensities  of  the  white  reference  and  the  vessel  branch, 
normalized  by  white  reference  intensity  following  Equation  4.1, 
 (4.1) 
where  I(n,λ)  is  vessel  branch  number  n,  intensity  at  λ  wavelength,  and  I(R,λ)  is  the  mean 
value  of  the  white  reference  intensity  at  λ  wavelength. 
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 Figure  4.3.  (a)  Vessels  branches  of  1–7  indicated  by  different  colors  on  a  regular 
white‐light  image  of  the  brain  image  through  the  open  skull  (condition  2).  The  inset 
shows  an  example  of  evenly  distributed  intensity  samples  along  the  midline  of  the  main 
vessel  of  the  branch  4,  which  were  used  to  calculate  the  vessel  branch  intensity.  (b) 
Regular  white‐light  images  and  laser  speckle  imaging  (LSI)  images  (scale  bars = 1 mm). 
(c)  Contrast  intensity  profiles  of  lines  across  the  images  (shown  as  a  dashed  line  in  panel 
(a).  The  inset  in  (c)  shows  how  LSI  noise  parameters,  |ΔK|  and  fall  distances  are 
determined  from  the  line  profiles. 
 
Rebuilding  Arteriovenous  Cerebral  Blood  Flowmetry  Map  Based  on  MSRI‐LSI  
Step  1:  Constructing  a  flow  map  using  laser  speckle  temporal  contrast  analysis  (LSTCA) 
The  contrast‐resolved  LSI  images  were  constructed  in  the  same  manner  as  the 
Chapter  3,  based  on  the  temporal  statistical  analysis  of  laser  speckle,  which  has  been 
proven  to  preserve  spatial  resolution. 
Step  2:  Arteriovenous  vasculature  network 
The  vasculature  network  was  extracted  from  the  LSI  image  according  to  the 
difference  in  flow  velocity  between  the  vasculature  and  tissue.  A  Hessian‐based  filtering 
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algorithm  was  then  used  to  enhance  contrast  and  connectivity  in  the  image  of  the 
vasculature 130 .  In  this  step,  vessels  are  detected  using  the  eigenvalues  of  the  image,  and 
detection  is  sensitive  to  vessels  in  any  orientation.  Vessel  detection  was  performed  over 
multiple  vessel  scales  (from  ~20  to  400 µm  in  diameter),  and  the  maximum  filter 
response  for  each  pixel  was  used.  The  resulting  image  was  thresholded  to  produce  a 
binary  mask  of  the  vasculature.  The  arteriovenous  information  obtained  by  MSRI  was 
then  registered  on  the  vasculature  network  obtained  by  LSI,  and  veins  and  arteries  were 
labeled  on  the  vasculature  network  LSI  images. 
Step  3:  Weighting  the  arteriovenous  vasculature  network  by  the  blood  flow  map  
Finally,  the  resulted  arteriovenous  vasculature  network  was  weighted  by  the 
calculated  LSTCA  relative  blood  flow  information. 
Quantitative  Analysis  of  the  LSI  Resolution  and  Contrast 
We  assessed  the  quality  of  the  speckle  contrast  images  in  terms  of  signal  to  noise 
ratio  (SNR)  and  vessel  sharpness,  in  the  same  manner  as  Chapter  3.  The  profile  lines 
were  chosen  based  on  the  open‐skull  images  such  that  four  vessels  were  intersected.  The 
same  spatial  location  (i.e.,  same  vessels)  were  analyzed  in  the  through‐skull  and 
through‐implant  conditions  as  well.  When  imaging  through  skull,  one  of  the  four  vessels 
was  not  visible  and  was  omitted  from  the  analysis  of  that  condition.  Figure  4.3(c)  shows 
an  example  of  the  contrast  intensity  profile  for  the  brain  with  open  skull,  through‐skull, 
and  through‐implant. A  visual  example  of  Δ K (Signal)  and  σ Kn (Noise)  are  shown  in 
Figure  4.3(c).  The  SNR  values  were  averaged  over  the  profile  vessels  and  standard  errors 
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were  calculated.  Sensitivity,  which  is  considered  as  the  ratio  of  the  mean  SNR  to  the 
mean  SNR  of  the  reference,  was  calculated  using  Equation  4.2 
 (4.2) 
As  an  indicator  of  resolution,  we  compared  the  sharpness  of  the  vessel  edges  in 
images  by  calculating  the  fall  distance,  (as  explained  in  Chapter  3) 131 .  A  shorter  fall 
distance  corresponds  to  greater  sharpness.  Figure  4.3(c)  shows  an  example  trace  and 
10–90%  fall  distance  measurement.  To  compare  the  blood  vessel  images  through‐skull 
and  through‐implant,  the  fall  distances  were  determined  and  averaged  over  the  profile 
vessels  and  the  standard  errors  were  calculated. 
Results 
Through‐Skull  and  Through‐Implant  MSRI  Images 
The  mapped  vasculature  branches  and  vein‐artery  separated  network  from 
open‐skull  imaging  (i.e.,  condition  2)  are  shown  in  Figure  4.4(a)  and  4.4(b),  respectively. 
Figure  4.4(d)  shows  the  spectral  behavior  of  the  branches.  The  dashed  line  in  Figure 
4.4(d)  shows  the  mean  optical  extinction  of  all  seven  branches.  Overall,  optical  extinction 
is  relatively  high  for  wavelengths  of  560–580 nm.  A  drastic  decrease  in  optical  extinction 
happens  at  wavelengths  of  590,  600,  and  610 nm.  Notably,  the  vessel  branches  1  and  4 
show  a  different  trend  compared  to  branches  2,  3,  5,  6,  and  7.  These  two  groups  were 
labeled  in  red  and  blue  and  the  mean  (solid  lines)  and  standard  deviation  (colored 
shadow)  of  each  group  were  separately  calculated  and  shown.  The  blue  group  including 
branches  1  and  4  resulted  in  higher  optical  extinction  at  560 nm.  At  wavelengths  of  570 
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and  580 nm,  red  group  showed  the  extremum  values.  Optical  extinction  values  of  red 
group  have  a  higher  decrease  than  the  blue  group  at  590 nm  and  show  lower  optical 
extinction  values  at  wavelengths  of  590,  600,  and  610 nm  than  the  blue  group. 
Comparing  the  relation  between  red  and  blue  groups  to  the  reported  configuration  of 
oxyhemoglobin  and  deoxyhemoglobin  chromophores,  optical  extinction  coefficients  in 
the  wavelength  range  of  560–610 nm 132  illustrates  the  existence  of  a  higher  concentration  
of  oxyhemoglobin  and  relatively  lower  concentration  of  deoxyhemoglobin  in  the  red 
group  (vessel  branches  2,  3,  5,  6,  and  7)  than  the  blue  group  (vessel  branches  1  and  4). 
 
Figure  4.4. Cerebral  arteries‐veins  separation  using  multispectral  reflectance  imaging 
(MSRI),  in  open  skull  imaging  (i.e.,  condition  2).  (a)  Labeling  the  vasculature  branches 
on  a  regular  white‐light  image.  The  images  were  converted  to  gray  color  map  to  make  the 
colored  vasculature  branches  clear.  (b)  The  separated  veins  (blue)  and  arteries  (red)  (scale 
bars = 1 mm).  (c)  Optical  images  of  the  brain  illuminated  by  various  wavelengths.  (d) 
Relative  optical  absorption  values  plotted  for  each  branch. 
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A  regular  white‐light  image  of  the  closed  mouse  skull  (i.e.,  condition  1)  is  shown 
in  Figure  4.5(a).  The  MSRI  images  captured  through  the  cranial  bone  of  the  mouse  do  not 
show  the  vasculature  network.  Consequently,  we  were  not  able  to  identify  the  vessels 
branches  and  their  intensities  over  the  multispectral  images  in  Figure  4.5(b). 
 
Figure  4.5. The  multispectral  reflectance  imaging  (MSRI)  through  closed  skull 
(i.e.,  condition  1).  (a)  Regular  white‐light  image  of  the  skull.  The  image  was 
converted  to  gray  color  map  to  increase  contrast.  (b)  Optical  images  of  the  mouse 
skull  illuminated  by  various  wavelengths.  As  seen,  the  vasculature  map  is  not 
evident  when  imaged  through  skull  (scale  bars = 1 mm). 
 
Figure  4.6(a)  shows  mapped  vasculature  branches  on  a  regular  white‐light  image 
through  the  WttB  implant  (i.e.,  condition  3).  Multispectral  images  as  shown  in  Figure 
4.6(c)  resulted  in  a  notable  lower  contrast  compared  with  the  references  images  (Fig ure 
4.4(c)).  The  spectral  behavior  of  the  branches  is  plotted  in  Figure  4.6(d).  The  dashed  line 
indicating  the  overall  mean  optical  extinction  for  all  seven  branches  shows  a  general 
decrease  in  the  relative  optical  extinction  compared  with  imaging  the  brain  directly 
(Fig ure  4.4(c)),  which  is  due  to  the  reflected  light  from  the  WttB  implant  surface 
overcoming  the  vessels  optical  extinction.  Similar  to  the  direct  brain  images  (imaging 
condition  2),  the  mean  optical  extinction  (dashed  line)  is  relatively  high  for  wavelengths 
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of  560–580 nm,  followed  by  a  decrease  at  wavelengths  of  590,  600,  and  610 nm. 
Although  there  is  a  lower  deviation  between  the  optical  extinction  values,  the  separate 
trend  of  the  vessel  branches  1  and  4  compared  with  branches  2,  3,  5,  6,  and  7  is  still 
noticeable.  Accordingly,  these  two  groups  were  labeled  in  red  and  blue  and  the  mean  and 
standard  deviation  of  each  group  were  separately  calculated  and  shown  in  Figure  4.6(d). 
The  analysis  of  the  images  obtained  through  WttB  implant  (imaging  condition  3),  shows 
a  similar  conclusion  to  the  reference  data  (imaging  condition  2).  Although  the  relative 
optical  extinction  values  have  a  notably  higher  deviation  (which  affects  the  accuracy  of 
the  analysis)  compared  with  imaging  the  brain  directly,  the  vein‐artery  separation  is 
indeed  doable  through  the  WttB  implant. 
 
Figure  4.6. Cerebral  arteries‐veins  separation  using  multispectral  reflectance  imaging 
(MSRI)  through  the  Window  to  the  Brain  (WttB)  implant  (imaging  condition  3).  (a) 
Labeling  the  vasculature  branches  on  a  regular  white‐light  image  of  the  implantation 
region  (condition  3).  (b)  The  separated  veins  (blue)  and  arteries  (red).  (c)  Optical  images 
of  the  brain  illuminated  by  various  wavelengths.  (d)  Normalized  mean  intensity  values 
plotted  for  each  branch. 
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Through‐Implant  and  Through‐Skull  LSI  Images 
Figure  4.3(b)  shows  regular  white‐light  images  and  LSI  temporal  contrast  images 
of  brain,  through‐skull,  and  through‐implant.  It  should  also  be  noted  that  after  the  surgery, 
blood  flow  is  expected  to  be  altered  in  response  to  the  invasive  craniectomy  surgery  (e.g., 
due  to  potential  reactive  hyperemia 133  (increased  blood  flow),  changes  in  respiration,  
etc.).  We  previously  reported  the  optimal  exposure  time  for  LSI  imaging  at  each  time 
point,  so  that  we  could  compare  the  images  of  highest  SNR  that  could  be  acquired  of  the 
brain,  through‐skull,  and  through‐implant. 
Line  intensity  profiles  like  the  example  shown  in  Figure  4.3(c)  were  analyzed  for 
the  brain,  through‐skull,  and  through‐implant  contrast  images.  To  avoid  selection  bias, 
the  location  of  these  line  profiles  were  chosen  arbitrarily  at  the  region  of  interest  (ROI) 
mid‐points,  as  depicted  in  the  regular  white‐light  image  in  Figure  4.3(b).  From  these 
intensity  profiles,  peak  intensity  and  noise  were  determined  (as  described  in  the  Methods 
section  and  illustrated  in  the  inset  of  Fig ure  4.3(c)),  and  SNR  ratio  was  calculated.  Data 
for  each  imaging  condition  was  averaged  between  the  vessels  and  the  mean  SNR  for  each 
imaging  condition  is  shown  in  Figure  4.7(a).  As  expected,  the  brain  contrast  image  shows 
the  highest  SNR  (imaging  condition  2).  The  through‐implant  contrast  image  (imaging 
condition  3)  resulted  in  the  higher  SNR  compared  with  the  through‐skull  contrast  image 
(imaging  condition  1)  by  17.59%  (relatively). 
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 Figure  4.7.  (a)  Mean  signal  to  noise  ratio  (SNR)  of  contrast  intensity  and  (b)  mean  fall 
distance  of  contrast  intensity  along  arbitrary  line  profiles  on  the  brain,  skull,  and  Window 
to  the  Brain  (WttB)  implant. 
 
Sensitivity  was  calculated  and  resulted  in  96.82%  for  the  through‐implant  image 
(imaging  condition  3)  and  86.1%  for  the  through‐skull  image  (imaging  condition  1). 
Then,  we  compared  the  sharpness  (i.e.,  fall  distance)  of  the  vessels  in  the  images  to 
determine  if  the  images  were  becoming  blurred  and  losing  resolution  through  the  WttB 
implant.  The  mean  fall  distance  for  each  imaging  condition  is  shown  in  Figure  4.7(a). 
The  through‐implant  contrast  image  (imaging  condition  3)  provided  5.7 µm  lower  fall 
distance  (higher  sharpness)  when  compared  with  the  through‐skull  contrast  image 
(imaging  condition  1). 
Assessing  Arteriovenous  Blood  Flow  Through‐Implant 
Figure  4.8  demonstrates  the  process  of  arteriovenous  cerebral  microcirculation 
image  generation  and  the  images  obtained  through  each  step.  First,  an  LSI  image  is 
acquired,  which  contains  information  on  vessel  structures  and  relative  flow  velocities. 
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The  LSI  image  is  also  thresholded  to  provide  a  contrasted  vessel  map  as  a  reference 
vasculature  network  (step  1).  Next,  MSRI  imaging  allows  for  separating  cerebral  veins 
and  arteries  based  on  optical  extinction  spectra  over  the  wavelengths  560–610 nm,  and 
this  arteriovenous  information  is  overlaid  on  the  vasculature  network  LSI  image  (step  2). 
Finally,  the  arteriovenous  vasculature  network  image  is  weighted  by  the  relative  blood 
flow  velocities  obtained  during  the  initial  LSI  imaging  in  step  1  (step  3). 
 
Figure  4.8.  The  steps  of  constructing  an  arteriovenous  microcirculation  image.  (a)  Laser 
speckle  imaging  (LSI)  image  obtained  by  temporal  analysis  of  laser  speckle  images.  The 
LSI  images  were  then  processed  to  generate  the  LSI  vessel  map,  where  bright  is  the 
vasculature  network  and  dark  is  the  non‐vascular  region  (step  1).  (b)  Arteriovenous 
information  from  multispectral  reflectance  imaging  (MSRI)  is  registered  onto  LSI 
vasculature  network  obtained  using  LSI  (step  2).  (c)  Arteriovenous  vascular  network  is 
weighted  by  the  blood  flow  map  (LSI  image)  (step  3).  Bar = 1 mm. 
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Discussion 
In  this  study  we  assessed  the  feasibility  of  MSRI‐LSI  imaging  of  the  brain 
microcirculation  through  the  WttB  implant.  Other  studies  have  investigated  various 
methods  of  vein‐artery  separation,  including  velocity‐based 134 ,  optical  attenuation‐based 
methods  other  than  MSRI,  and  structural‐based  separation 135 .  Besides  the  various 
proposed  methods  based  on  multi‐wavelength  imaging 136 ,  like  the  MSRI  approach  we 
used  in  this  present  study,  Miao  et  al.  distinguished  arteries  and  veins  by  vascular 
anatomical  features  and  optical  intensity  profiles  in  single‐wavelength  laser  speckle 
contrast  imaging  (SW‐LSCI)  images,  but  arteries  and  veins  may  be  misclassified  because 
of  similar  absorption  to  the  cerebral  cortex.  Feng  et  al. 137  proposed  an  automatic  
vein‐artery  separation  method  based  on  imaging  the  exposed  cerebral  cortex  using 
SW‐LSCI,  however,  the  absorption  and  scattering  of  underlying  parenchyma  would  also 
influence  the  accuracy  of  the  vein‐artery  separation.  Our  method  for  accessing  the 
intrinsic  information  of  blood  using  MSRI  with  six  wavelengths  utilizes  more  complex 
instrumentation  than  many  of  these  other  reported  methods  of  vein‐artery  separation 138 . 
Our  reason  for  choosing  the  MSRI  method  over  less  complex  vein‐artery  separation 
methods  was  that  MSRI  allows  for  functional  imaging,  which  can  be  useful  in  our  future 
functional  brain  imaging  studies  through  the  WttB  implant.  However,  limitations  exist  for 
extracting  componential  information  from  intrinsic  optical  signals  (IOSs).  Optical 
properties  of  blood  constituents  other  than  hemoglobin  (Hb),  may  absorb  or  scatter  light, 
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and  these  may  alter  the  optical  transmission  of  blood  vessels,  which  can  affect  the 
measurement  of  hemoglobin. 
The  analysis  of  the  MSRI  images  acquired  through  the  open  craniectomy 
(condition  2)  clearly  shows  the  different  spectral  behaviors  of  veins  and  arteries.  For  all 
vessels  imaged,  veins  showed  greater  optical  extinction  in  wavelengths  of  560,  590,  600, 
and  610 nm,  while  arteries  showed  greater  optical  extinction  at  wavelengths  of  570  and 
580 nm.  When  the  brain  was  imaged  through  skull  (condition  1),  only  the  main  vessels 
were  barely  visible  and  analysis  of  MSRI  for  the  microcirculation  was  not  practical.  On 
the  other  hand,  the  MSRI  images  obtained  through  the  WttB  implant  (condition  3) 
resulted  in  a  clear  map  of  the  vessels,  although  some  of  the  microvessels  were  not  visible. 
Comparing  the  vessel  branches  optical  extinction  shows  similar  results  to  the  reference 
data  (condition  2).  Branches  1  and  4  were  detected  as  vein  with  higher  optical  extinction 
at  560,  590,  600,  610 nm  and  branches  2,  3,  5,  6,  and  7  resulting  in  higher  optical 
extinction  at  570  and  580 nm  were  thus  identified  as  arteries.  This  result  demonstrates 
that  WttB  implant  can  allow  for  reliable  vein‐artery  separation  imaging.  It  is  worthwhile 
to  mention  that  the  images  captured  through  the  WttB  implant  have  lower  contrast,  which 
limits  the  accuracy  of  the  measurements  when  compared  with  imaging  the  brain  directly. 
Lower  average  of  optical  extinction  values  in  images  through  the  WttB  implant  (16.98%) 
compared  with  open  skull  images  (22.33%)  shows  this  poorer  contrast.  Consequently, 
this  lower  contrast  resulted  in  lower  accuracy  of  the  measurement  shown  by  higher  SD  of 
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red  and  blue  groups.  Averaged  SD  of  red  and  blues  groups  is  relatively  increased  by  33% 
and  31%,  respectively,  compared  with  open  skull  images. 
Temporal  contrast  imaging  has  become  a  useful  tool  for  brain  blood  flow 
applications  as  the  images  it  produces  contain  functional  information  (i.e.,  relative  blood 
velocity)  in  addition  to  showing  structure  of  the  vessel  networks.  As  we  previously 
reported,  exposure  time  of  6  ms  gave  the  highest  SNR  for  both  skull  and  WttB  implant 
and  was  used  for  comparing  SNR  and  sharpness  of  vessels  imaged  beneath  each.  Unlike 
our  previous  study  with  compared  two  different  spatial  regions,  here  the  comparison  was 
made  between  three  different  imaging  conditions.  Thus,  SNR  and  sharpness  of  vessels 
(fall  distance)  are  evaluated  for  an  identical  target.  Accordingly,  we  were  able  to  compare 
the  SNR  values  of  through‐implant  and  through‐skull  images  to  the  reference  image 
(open  skull)  to  evaluate  the  sensitivity.  This  supplementary  information  to  our  previous 
study  on  SNR  further  demonstrates  that  the  SNR  of  through‐implant  image  is  higher  than 
that  of  through‐skull  imaging.  Vessels  imaged  through  the  WttB  implant  have  shorter  fall 
distances,  while  vessels  imaged  through  the  skull  have  greater  fall  distances,  indicating 
that  vessels  imaged  through  the  implant  have  sharper  borders  compared  to  those  imaged 
through  the  skull.  As  the  size  of  vessels  and  velocity  of  blood  flow  is  not  expected  to 
differ  on  average  between  the  two  imaging  conditions,  the  apparent  increase  in  vessel 
diameter  imaged  through  the  skull  versus  WttB  implant  is  likely  due  to  the  blurring  of  the 
image  through  the  skull.  In  general,  the  light  transmission  to  the  brain  and  reflection  from 
the  brain  are  lower  in  the  through‐skull  image.  Additionally,  the  skull  scattering  disorders 
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the  speckle  pattern  that  was  created  by  the  brain  hemodynamics.  The  skull  poses  these 
same  issues  for  the  MSRI  imaging  as  well,  and  because  the  skull  texture  is  not 
homogeneous,  image  correction  or  enhancement  is  very  complex 114 .  The  reduction  in 
border  sharpness  of  the  vessels  imaged  through  the  skull  versus  WttB  implant  is 
consistent  with  this  explanation,  and  the  blurred  nature  of  the  through‐skull  image 
compared  with  the  through‐implant  image  is  visually  apparent  in  Figure  4.3(b).  It  should 
also  be  noted  that  while  the  SNR  and  sharpness  of  the  through‐implant  images  are  an 
improvement  over  the  through‐skull  images,  the  mouse  skull  is  inherently  transparent 
itself 114 ,  which  is  not  the  case  in  larger  animals  or  humans. 
While  vein‐artery  separation  is  possible  by  MSRI  alone,  in  this  study  we  combine 
MSRI  with  LSI.  The  combination  with  LSI  has  two  major  benefits.  First,  some  of  the 
microvessels  are  not  visible  through  the  WttB  implant  by  MSRI  since  the  transmitted 
light  could  not  overcome  the  reflected  light  from  the  surface  of  the  implant  for  these 
visible  wavelengths  (560–610 nm),  and  the  microvessels  have  low  contrast  when 
compared  with  larger  vessels.  Registering  the  information  from  the  MSRI  to  the  LSI  flow 
map,  which  does  show  the  microvessels,  helped  to  extend  the  arteriovenous  information 
to  the  smaller  vessel  sizes,  which  were  not  visible  by  MSRI.  Second,  LSI  imaging 
contains  functional  information  (relative  blood  velocity),  so  combining  these  methods 
produces  vasculature  maps,  which  show  relative  velocities  of  flow  within  the  separated 
arteries  and  veins.  Figure  4.8  contains  an  example  of  how  this  method  can  produce 
arteriovenous  vasculature  network  images  weighted  by  relative  blood  flow  velocity. 
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As  seen  in  Figure  4.3(b),  much  more  precise  velocity  information,  particularly  of 
microvessels,  can  be  detected  through  the  WttB  implant,  while  the  reduced  sharpness  of 
the  vessels  imaged  through  skull  obscures  precise  flow  determinations  (Figures  4.3(b) 
and  4.7).  Imaging  microvessels  (usually  involving  small  arteries  of  less  than  150 μm  in 
diameter,  arterioles,  capillaries,  and  venules)  is  important  for  many  applications,  as 
microcirculation  plays  a  critical  role  in  physiological  processes  such  as  tissue 
oxygenation  and  nutritional  exchange.  Monitoring  the  spatiotemporal  characteristics  of 
microcirculation  is  crucial  for  studying  the  normal  and  pathophysiologic  conditions  of 
tissue  metabolism.  It  is  also  useful  for  assessing  microcirculatory  dysfunction  due  to 
disease  conditions  such  as  type  2  diabetes,  peripheral  vascular  disease,  atherosclerotic 
coronary  artery  disease,  obesity,  heart  failure,  Alzheimer's,  schizophrenia,  and 
hypertension,  among  others 139 .  In  addition,  quantification  of  dynamic  blood  flow, 
angiogenesis,  and  vessel  density  are  critical  for  monitoring  the  progression  of  wound 
healing 140 .  Although  high‐resolution  vascular  network  mapping  is  possible  using  imaging 
modalities  such  as  CT,  these  approaches  require  injection  of  contrast  agents  and  pose 
disadvantages  such  as  radiation  exposure.  Existing  noninvasive  methodologies  (including 
LSI  through  skull)  are  inadequate  to  study  blood  flow  at  microvessel  resolution 122 . 
Windows  such  as  the  WttB  implant  are  thus  important  tools  for  research,  and  in  the  case 
of  the  WttB  implant  can  become  important  enablers  of  clinical  diagnostics  and  therapy 
involving  cerebral  microvessels. 
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There  are  several  limitations  to  the  current  study.  The  sample  size  used  was  small 
( n  = 1),  and  further  experiments  are  needed  to  confirm  the  reproducibility  of  these 
findings.  While  a  permanent  cranial  implant  can  allow  for  less  invasive  imaging  of  the 
brain  at  later  time  points,  it  requires  an  initial  implantation  surgery,  which  carries 
associated  risks  such  as  infection. 
In  conclusion,  this  study  has  demonstrated  the  ability  to  perform  MSRI‐LSI 
across  a  transparent  cranial  implant,  to  allow  for  cerebral  vessel  networks  to  be  mapped, 
including  microvessels.  These  images  contain  additional  information  such  as  vein‐artery 
separation  and  relative  blood  flow  velocities,  information  which  is  of  value  scientifically 
and  medically.  The  WttB  implant  provided  substantial  improvements  over  imaging 
through  the  murine  cranial  bone,  where  microvessels  are  not  visible  and  MSRI  cannot  be 
performed. 
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Chapter  5.  Enhanced  near  infrared  optical  access  to  the  brain  with  WttB  implant 
and  scalp  optical  clearing 
The  brain  is  protected  by  different  tissue  layers,  each  of  them  having  different 
optical  properties  (e.g.,  refractive  index  contrast,  scattering  and  absorption);  hence,  the 
analysis  of  the  spectral  features  provide  information  about  these  different  layers 54 . 
Furthermore,  it  has  been  shown  that  physiological  changes  in  the  different  head  tissues 
produce  variations  in  their  optical  properties  thereby  changing  the  spectral  features  of  the 
transmitted  and  reflected  light 47 .  Compared  to  visible  light,  some  spectral  regions  in  the 
Near  Infrared  (NIR)  spectral  range  (800  to  2500  nm)  offers  advantages  such  as  reduced 
scattering  and  absorption  as  well  as  a  deeper  penetration  depth  in  tissue  media 48,49 . 
Because  of  these  features,  some  spectral  windows  within  the  NIR  wavelength  range  have 
shown  promising  results  for  brain  studies,  including  deep  imaging,  diagnostics  and 
therapeutic  applications  in  brain  diseases 51 . 
Different  optically  transparent  windows  for  head  tissues  have  been  identified 
within  the  NIR  spectral  range.  These  wavelength  windows  avoid  light  attenuation  by  the 
tissue  due  to  water  absorption  peaks  located  at  1450  nm  and  1940  nm 55 .  The  first  window 
NIR-I  (∼700−1000  nm),  or  conventional  window,  has  been  well  characterized  and 
studied  for  most  tissues,  including  brain  and  other  soft  tissues.  Two  additional  optical 
windows  have  been  also  identified:  NIR-II  (∼1000−1350  nm)  and  NIR  -III,  or  short 
-wave  infrared  SWIR,  (∼1550−1870  nm);  the  latter  spectral  region  has  shown  to  provide 
maximum  light  penetration  for  some  kinds  of  tissues 141 .  More  recently,  a  fourth  optical 
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window,  SWIR-II  (∼2100−2300  nm)  has  allowed  for  improved  optical  studies  of  the 
brain  and  for  deep  brain  imaging,  particularly  when  compared  to  the  NIR  -II  window 53 . 
All  of  these  spectral  regions  have  been  explored  for  many  biophotonic  applications, 
although  the  NIR  windows  have  particularly  shown  excellent  potential  for  noninvasive 
through-skull in  vivo  brain  imaging  and  spectroscopy 52 .  Nonetheless,  it  is  always 
desirable  to  reduce  the  highly  scattering  cranial  bone  over  the  cortex,  which  hinders  the 
observation  of  optical  signals  deriving  from  deeper  tissues  and  reduce  the  light 
penetration  distance. 
In  this  chapter,  we  report  on  the  enhancement  in  optical  access  provided  by  the 
transparent  YSZ  implant  for  brain  studies  in  the  NIR  wavelength  range.  Because  this 
cranial  implant  is  sought  as  a  means  to  obtain  optical  access  for  post-operatory  and 
prolonged  diagnostics  and/or  therapy  purposes,  scalp  scattering  must  be  overcome.  In  this 
context,  we  also  evaluate  the  use  of  optical  clearing  agents  (OCAs)  in  the  scalp, 
particularly  their  effects  on  the  optical  transmittance  in  the  NIR  spectral  range.  As  shown 
in  previous  reports,  OCAs  provide  greater  optical  probing  depths  and  better  contrast,  as 
well  as  improved  light  focusing  and  spatial  resolution 142–144 .  Therefore,  evaluation  of  the 
optical  features  of  the  YSZ  implant  together  with  the  use  of  OCAs  in  the  NIR  spectral 
range  will  provide  useful  information  for  theranostics  applications  operating  in  this 
wavelength  range  (e.g.,  photobiomodulation 57–59 ,  NIR  and  fluorescence  imaging 145 ,  cancer 
diagnosis 146  and  brain  edema 147 ).  Hence,  we  evaluate  the  enhancement  in  optical  access  to  
the  brain  upon  comparing  ex-vivo  transmittance  measurements  of  mice  native  skull  and 
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the  YSZ  cranial  implant  coupled  with  scalp  and  OCAs.  Using  the  transmittance  data,  the 
total  attenuation  lengths  were  calculated  showing  that  this  combination  (YSZ  and  OCAs) 
offers  the  best  option  for  gaining  improved  optical  access  to  the  brain. 
Methods 
Scalp  and  skull  samples 
The  tissue  samples  were  obtained  from  animals  from  the  University  of  California, 
Riverside  (UCR).  All  experimental  procedures  and  humane  care  of  mice  were  conducted 
under  a  protocol  approved  by  UCR’s  Institutional  Animal  Care  and  Use  Committee,  and 
in  conformance  with  the  Guide  for  the  Care  and  Use  of  Laboratory  Animals  published  by 
the  National  Institutes  of  Health  (NIH  Publication  No.  85-23,  revised  1996).  The  N=9 
8-12  week  old  C57Bl/6  male  mice  (Jackson  Laboratory)  used  in  this  study  were  housed 
under  a  12-hour  light  and  12-hour  dark  cycle  with  ad  libitum  access  to  food  and  water.  
Surgical  procedures  
Craniectomy  surgery  was  conducted  as  previously  described.  Briefly,  mice  were 
anesthetized  with  isoflurane  inhalation  (0.2-0.5%),  and  given  ketamine  and  xylazine 
(K/X)  (80/10  mg/kg,  i.p.).  Additional  anesthetic  was  administered  as  necessary.  Hair  was 
removed  from  the  scalp  using  clippers  and  depilatory  cream.  Mice  were  then  secured  into 
stereotaxic  frames  to  immobilize  the  head  for  surgery.  Ophthalmic  ointment  was  placed 
over  the  eyes,  and  the  surgical  site  was  sterilized  with  alternating  application  of  betadine 
and  70%  EtOH  (3  times).  A  sagittal  incision  was  made  to  the  left  of  the  midline,  and  the 
scalp  excised  to  expose  the  skull.  Periosteum  was  removed  from  the  skull,  and  a 
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craniectomy  was  performed  with  a  surgical  drill  and  carbide  burr  to  remove  a  square 
section  of  skull  over  the  right  parietal  lobe,  with  dimensions  slightly  larger  than  the 
implant  (2.6  x  2.6  mm). 
Optical  clearing 
A  mixture  of  two  biocompatible  agents,  PEG-400  (PEG)  and  Propylene  Glycol 
(PG)  (Fisher  Scientific,  California,  US),  were  used  as  scattering  reducer  and  penetration 
enhancer,  respectively,  at  a  volume  ratio  of  9:1 148,149 .  The  OCA  was  prepared  and 
topically  applied  at  room  temperature.  A  thin  layer  of  the  OCA  was  applied  on  the 
sample  and  remained  for  50  minutes 148 .  Characterization  experiments  were  performed 
before  and  immediately  after  applying  the  OCA;  the  increase  in  transmittance  for  each 
tissue  used  in  the  samples  was  monitored  every  minute  over  a  50-minute  period.  For  our 
experimental  conditions,  the  maxima  in  transmittance  were  achieved  within  50  minutes. 
Tissue  characterization 
Optical  transmittance  measurements  of  the  different  samples  used  in  this  study 
were  obtained  through  optical  spectrometry  in  the  NIR.  The  setup  used  to  obtain  the 
transmittance  spectra  incorporates  two  multimode  optical  fibers  (P400-2-VIS-NIR, 
Ocean  Optics,  FL)  attached  to  individual  fiber  holders  including  VIS-NIR  collimating 
lenses  (MP-74-UV,  Ocean  Optics,  FL,  with  focal  length  f  =  10mm,  lens  diameter  D  = 
5mm  and  N  A  =  D/2  f  =  0.4).  As  depicted  in  Fig ure  5.1,  the  holders  were  attached  to  a 
mechanical  rail  allowing  to  adjust  the  separation  between  the  fibers  and  to  allocate  a 
sample  holder.  After  the  sample  is  fixed,  the  fiber  holders  were  tightly  joined  together  to 
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mitigate  detrimental  effects  from  ambient  light  and  back  reflections.  The  light  source 
used  for  these  measurements  was  a  visible-NIR  source  (HL2000  FHSA,  Ocean  Optics, 
FL)  launched  into  one  of  the  optical  fibers.  The  beam  exiting  the  launching  fiber  then 
traverses  the  sample  and  is  collected  by  the  other  fiber,  which  is  connected  to  a  solid-state 
spectrometer  (NIRQUEST  520,  Ocean  Optics,  FL)  to  obtain  the  optical  transmission 
spectra.  Spectra  were  acquired  averaging  10  measurements,  with  an  integration  time  of 
300  ms,  in  the  900-2400  nm  wavelength  range. 
 
Figure  5.1. Collimated  transmittance  measurements  setup.  The  inset  shows  the  housing 
for  fixing  the  sample,  i.e.,  the  fiber  holders  with  the  VIS-NIR  collimating  lenses.  As  seen 
in  the  inset,  the  samples  are  placed  between  coverslips  (see  text  for  further  details).  
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For  all  the  measurements,  the  collimated  transmittance  (T(λ))  was  calculated  as 
the  ratio  of  light  transmitted  through  the  sample  to  the  total  incident  light,  i.e.:  
    (5.1) 
where  λ  is  the  wavelength,  S  is  the  measured  spectral  intensity,  I  is  the  total  light  incident 
and  D  represents  the  reference  reading  under  dark  conditions  (i.e.,  no  light  impinging  on 
the  sample).  Basic  models  of  light  propagation  in  biological  tissues  are  described  in  terms 
of  radiation  transport  in  a  random  inhomogeneous  media,  which  includes  ballistic  and 
diffuse  light.  However,  when  using  a  collimated  beam,  and  in  the  case  of  thin  samples 
with  large  absorption  coefficients  and  relatively  small  light  scattering,  the  ballistic  part 
plays  a  dominant  role  and  the  diffusive  part  is  negligible 47,50,53,150 .  We  further  consider  that 
the  ballistic  photons  in  the  scattering  samples  are  governed  by  the  Beer-Lambert  law. 
Hence,  for  analyzing  the  influence  of  the  sample  thickness  z  in  the  spectral  transmittance, 
the  total  attenuation  length  (lt(λ))  was  calculated  as 47,50,53,150 : 
 (5.2) 
Note  that  the  attenuation  length  takes  into  account  the  sample  thickness  and  therefore 
provides  a  better  insight  of  the  light  penetration  through  the  samples.  In  particular,  for  our 
experiments,  the  thicknesses  of  the  samples  are:  440  ±  1µm,  159  ±  1µm  and  710  ±  20µm 
for  the  YSZ  implant,  the  mice  skull  and  scalp,  respectively.  Hence,  the  YSZ  implant  is 
2.5  times  thicker  than  the  mice  skull.  
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Experimental  method 
The  experimental  procedure  for  measuring  the  ballistic  transmittance  through  the 
different  tissues  and  the  implant  was  similar  to  those  reported  previously  for 
spectroscopic  measurements  on  soft  tissue 47,50,53,150 .  Transmittance  measurements  were 
obtained  for  three  sets  of  samples  arranged  as  the  different  scenarios  illustrated  in  Fig ure 
5.2.  Spectra  were  obtained  first  for  the  skull  and  subsequently  for  the  stacked  array 
formed  by  the  scalp  placed  on  top  of  the  skull.  The  OCAs  were  then  applied  on  the  scalp 
and  the  spectral  transmittance  was  acquired  once  again.  This  set  of  measurements  were 
also  performed  using  the  YSZ  implant  instead  of  the  skull.  The  stacking  arrangement 
used  for  this  measurements  allowed  for  evaluating  the  effects  of  each  layer  on  the 
spectral  features  of  the  sample.  This  further  allows  for  comparing  the  spectral  features  of 
the  skull  and  the  YSZ  implant  under  similar  conditions.  Excised  full  thickness  scalp  and 
forehead  cranial  bone  were  rinsed  briefly  in  saline  solution  to  remove  the  excess  blood 
and  their  thicknesses  were  measured  before  placing  them  in  the  stacked  samples.  These 
were  finally  placed  between  two  glass  microscope  coverslips  to  obtain  the  transmittance 
spectra.  The  same  procedure  was  followed  for  the  YSZ  implant.  For  the  cleared  skin 
measurements  the  scalps  were  topically  exposed  to  PEG  and  PG  as  a  scattering  reducer 
and  a  penetration  enhancer,  respectively 148,149 . 
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 Figure  5.2.  Stacked  sample  arrangement  used  to  obtain  the  spectral  transmittance  of:  1) 
the  native  skull  and  YSZ  implant,  2)  the  scalp  on  top  of  the  skull  and  the  YSZ  implant,  3) 
optical  cleared  (OC)  scalp  on  top  of  native  skull  and  implant.  
 
Results  and  Discussion 
Figure  5.3  shows  the  transmittance  (T(λ))  and  the  attenuation  length  (lt(λ)) 
calculated  for  the  native  skull  and  the  implant.  The  transmittance  measurements  (Fig ure 
5.3(a))  show  that  the  YSZ  implant  is  more  transparent  throughout  the  tested  NIR  range 
(900-2400  nm)  including  all  of  the  optical  windows  commonly  used  for  biophotonic 
applications  (i.e.,  NIR  I,  NIR  II,  SWIR  I  and  SWIR  II).  This  is  due  to  the  significant 
reduction  in  scattering  and  absorption  when  using  the  YSZ  implant.  In  terms  of  relative 
differences  in  the  optical  properties  between  skull  and  the  implant,  the  latter  improves  the 
light  transmission  within  the  water  absorption  bands  owing  to  its  reduced  water  content 
compared  to  the  native  skull  (70-75%).  The  skull  transmittance  shows  the  typical  water 
absorption  bands  in  the  NIR  spectral  region  (1450  nm  and  1940  nm),  while  the  YSZ 
implant  shows  improved  transmittance  in  these  bands.  The  water  absorption  peaks 
apparent  in  the  implant  spectrum  are  due  to  traces  of  the  saline  solution  used  for  rinsing 
aiming  at  obtaining  a  fair  comparison  with  the  treated  tissue  samples.  A  simple 
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calculation  of  the  increase  of  light  transmitted  in  these  bands  using  the  YSZ  implant 
compared  to  the  native  skull  yields  values  of  47%  at  1450  nm  and  53%  at  1940  nm.  The 
resulting  attenuation  length  shown  in  Fig ure  5.3(b)  further  indicates  that,  even  for  the 
spectral  regions  with  the  smallest  increase  in  transmission  (e.g.,  3%  at  1300  nm),  light 
can  penetrate  deeper  when  compared  to  the  native  skull.  Clearly,  with  exception  of  the 
second  water  absorption  band,  the  attenuation  length  obtained  with  the  implant  increases 
at  least  by  1.3  mm,  i.e.,  a  four-fold  increase  in  length  compared  to  the  skull  The  spectral 
regions  covered  by  the  water  absorption  peaks  in  the  NIR  have  not  been  explored  for 
through-skull  techniques  because  of  its  high  water  content.  Thus,  the  improved 
transmission  obtained  with  the  implant  opens  the  possibility  to  explore  new  techniques  in 
these  wavelength  ranges. 
 
Figure  5.3.  Transmittance  (a)  and  total  attenuation  length  (b)  for  the  skull  and  the  YSZ 
implant.  The  YSZ  implant  shows  better  transmittance  throughout  the  full  900-2400  nm 
spectral  range  compared  to  the  native  skull. 
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The  effect  of  the  scalp  on  the  spectra  is  evident  in  Fig ure  5.4(a),  showing  a 
considerable  reduction  in  transmission  owing  to  the  increased  scattering  inherent  to  this 
tissue 47 .  As  shown  in  Fig ure  5.4(b),  this  leads  to  reduced  attenuation  lengths  for  both 
sample  arrangements,  i.e.,  scalp  either  on  top  of  the  skull  or  on  the  YSZ  implant. 
Although  for  both  cases  the  scalp  stacking  leads  to  a  reduction  in  transmittance  of  at  least 
60%,  the  sample  with  the  implant  still  provides  the  best  performance,  as  confirmed  by  the 
attenuation  length.  Throughout  all  the  spectral  range,  the  sample  formed  with  the  scalp 
and  the  YSZ  implant  provides  improved  light  penetration.  Clearly,  the  scalp  introduces 
large  optical  attenuation  effects  that  must  be  overcome  for  the  implant  to  become  a 
convenient  means  to  obtain  access  for  non-invasive  optical  techniques  for  post-operatory 
diagnostics  and/or  therapeutic  purposes.  Hence,  we  evaluated  the  use  of  OCAs  as  a 
technique  for  improving  the  transmittance  of  the  samples.  
 
Figure  5.4.  Transmittance  (a)  and  total  attenuation  length  (b)  comparing  the  stacked 
samples  of  the  scalp  on  top  of  the  skull  and  on  the  YSZ  implant.  The  sample  with  the 
YSZ  implant  still  shows  better  transmittance  and  improved  attenuation  length  compared 
to  the  sample  with  the  native  skull;  however,  the  enhancement  is  only  of  6%  in  the  best 
case. 
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The  effects  of  applying  a  layer  of  OCAs  on  the  scalp  are  evident  in  Fig ure  5.5;  the 
transmittance  spectra  increases  by  20%  for  the  sample  with  the  skull,  while  for  the  YSZ 
implant  the  enhancement  is  40%  (Fig ure  5.5(a)).  As  shown  in  Fig ure  5.5(b),  the 
attenuation  length  for  both  samples  increases  accordingly;  when  compared  to  the  results 
shown  in  Fig ure  5.4(b),  it  is  clear  that  the  OCAs  effectively  enhance  the  light  penetration 
yielding  larger  attenuation  lengths  throughout  the  whole  NIR  range  for  both  samples. 
Further  comparison  of  this  parameter  for  the  two  samples  show  that  the  YSZ  provides 
improved  light  penetration  than  attained  with  the  skull  (up  to  1.8  mm  more  at  1717  nm). 
These  results  are  consistent  with  previous  reports  involving  OCAs 142–144 ,  and  further 
confirm  that  together  with  the  YSZ  implant,  these  biocompatible  agents  provide  attractive 
features  for  optical  access  to  the  brain  tissue  without  scalp  removal. 
 
Figure  5.5.  Transmittance  (a)  and  total  attenuation  length  (b)  comparing  the  stacked 
samples  of  the  scalp  on  top  of  the  skull  and  on  the  YSZ  implant  after  using  the  OCAs. 
The  sample  using  the  YSZ  implant  with  optically  cleared  scalp  (OC  scalp)  shows  an 
increase  of  up  to  30%  in  transmittance  compared  to  the  sample  with  the  skull. 
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A  better  idea  of  the  impact  of  our  results  in  each  of  the  NIR  optical  windows  can 
be  appreciated  in  Fig ure  5.6,  showing  a  summary  of  the  transmittances  and  attenuation 
lengths  obtained  from  our  experiments.  Comparing  all  the  scenarios,  the  YSZ  implant 
provides  the  best  option  for  optical  access,  showing  the  largest  transmittance  and 
attenuation  length.  Although  the  transmittance  for  the  YSZ  is  seemingly  comparable  to 
that  of  the  skull  for  the  NIR  II  and  NIR  III  windows,  the  attenuation  lengths  for  the 
implant  are  clearly  larger  than  those  obtained  for  the  skull  (Fig ure  5.6(b)).  In  fact,  for  all 
the  windows,  the  YSZ  implant  offers  improved  features  and  thus  better  potential  for 
deeper  optical  access  to  the  brain  tissue,  even  when  using  the  scalp  on  top.  When  using 
OCAs  to  reduce  the  scattering  of  the  scalp,  the  YSZ  implant  offers  improved 
transmittance  and  larger  attenuation  lengths  than  those  observed  for  the  skull. 
Remarkably,  the  attenuation  lengths  achieved  with  the  OCAs  and  the  YSZ  show  at  least  a 
two-fold  increase  for  the  last  three  windows  (i.e.,  NIR  II,  NIR  III-SWIR  I  and  SWIR  II). 
Evidently,  the  optical  features  offered  by  the  YSZ  implant  together  with  the  use  of 
biocompatible  agents  to  reduce  scalp  scattering  pose  new  possibilities  for  probing  brain 
tissue  in  spectral  regions  that  are  commonly  discarded  owing  to  the  low  penetration 
depths  that  can  be  commonly  achieved 50 .  Note  that  these  results  provide  a  direct 
comparison  of  the  attenuation  lengths  achieved  when  replacing  the  mice  skull  by  the  YSZ 
implant.  It  is  evident  that  the  transparency  of  the  YSZ  implant  improves  the  light 
penetration,  but  the  ultimate  increase  in  penetration  depth  achievable  will  depend  on  the 
scattering  features  of  the  specific  bone  tissue.  Further  considerations  for  the  analysis  of 
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the  spectral  transmission  should  include  the  diffuse  light  component,  which  is  relevant 
when  using  thicker  and  more  absorbent  tissue  samples  (e.g.,  rat  skull 50 ). 
 
Figure  5.6.  Summary  of  the  registered  transmittance  (a)  and  total  attenuation  length  (b) 
for  the  different  samples  tested  in  our  experiments.  Throughout  the  whole  NIR  spectral 
range  the  YSZ  implant  shows  enhanced  transmittance  among  all  the  samples.  The  use  of 
OCAs  on  the  scalp  effectively  increases  both,  the  transmittance  and  the  attenuation 
length,  providing  enhanced  light  penetration.  The  most  favored  optical  window  for  the 
stacked  sample  of  optically  cleared  scalp  on  top  of  the  YSZ  implant  is  the  NIR  III 
(1550-1870  nm,  T=67%,  lt=  2.86  mm).  Error  bars  represent  standard  deviation  (n=3). 
 
The  enhanced  transparency  of  the  YSZ  implant  coupled  with  the  OCAs  shows 
promising  features  to  facilitate  various  NIR  techniques  for  theranostics. 
Photobiomodulation  (600-1064  nm),  NIR  and  fluorescence  imaging  (700-1700  nm),  as 
well  as  some  types  of  cancer  diagnosis  (1500-1800  nm)  and  brain  edema  are  a  few 
examples  of  optical  techniques  that  could  benefit  from  the  improved  transmission  in  NIR 
spectral  range  offered  by  the  YSZ  implant.  Additionally,  any  potential  adhesion  of 
biochemical  agents  and/or  tissue  growth  on  the  implant  (e.g.,  fibrotic  tissue,  proteins,  cell 
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adhesion)  could  be  potentially  monitored  over  time  using  IR  reflection  techniques 25 . 
Imaging  techniques  (e.g.,  LSI,  fluorescence,  absorption)  that  have  been  successfully 
demonstrated  to  improve  with  clearing  and  thinning  skull  methods 33 ,  may  also  benefit 
from  the  combination  of  the  OCAs  and  a  transparent  YSZ  implant. 
We  have  evaluated  the  optical  transmission  and  attenuation  length  of  a  novel 
YSZ-based  implant  intended  for  chronic  optical  access  to  the  brain  performing  ex-vivo 
transmittance  measurements.  In  addition,  the  use  of  OCAs  to  overcome  the  low 
transparency  of  the  scalp  was  explored  together  with  the  implant.  Direct  comparison  of 
the  YSZ  implant  with  mouse  skull  in  different  stacked  arrangements  showed  that  this 
ceramic  material  offers  enhanced  transmission  throughout  the  NIR  spectral  range. 
Furthermore,  since  OCAs  effectively  reduce  the  scattering  features  of  the  scalp,  the  use  of 
these  biocompatible  agents  together  with  the  YSZ  implant  provide  improved  optical 
features.  In  particular,  when  compared  to  a  typical  arrangement  comprised  of  scalp  and 
native  skull,  the  use  of  the  YSZ  implant  yields  an  increase  in  transmittance  of  up  to  50% 
and  attenuation  lengths  of  up  to  2.4  mm  (i.e.,  a  five-fold  increase  in  light  penetration). 
These  experimental  results  show  evidence  that  the  YSZ  implant,  when  used  together  with 
the  OCAs,  offers  the  best  option  for  gaining  improved  optical  access  to  the  brain.  This 
novel  approach  seeks  to  provide  new  opportunities  for  monitoring  brain  conditions  on  a 
chronically  recurring  basis,  without  requiring  repeated  craniotomies  or  scalp  removal. 
Although  this  study  represents  only  the  first  step  towards  the  application  of  NIR  optical 
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techniques  for  brain  theranostics  through  an  implant,  it  offers  a  relevant  insight  of  the 
opportunities  that  this  transparent  material  may  eventually  provide. 
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Chapter  6.  Through-Scalp  Light  Delivery  and  Microcirculation  Imaging 
Background 
Providing  optical  access  in  visible  (VIS)  wavelength  range  to  the  human  brain  for 
light  delivery  and  microcirculation  imaging  is  complicated  due  to  the  static  and  dynamic 
effects  of  optical  scattering  and  absorption  (particularly  in  hemoglobin  absorption  picks) 
by  the  inhomogeneous  skull  and  scalp  tissues.  Therefore,  VIS  light-based  brain  studies 
has  been  predominantly  demonstrated  in  rodent  open-skull  and  thinned  skull  models.  In 
this  Chapter  I  report  on  the  VIS  light  delivery  through  the  WttB  implant.  The 
enhancement  in  optical  access  to  the  brain  using  scalp  optical  clearing  and  WttB  implant 
is  evaluated  through ex  vivo  optical  transmittance  measurements.  We  also  performed in 
vivo  brain  microcirculation  imaging  in  mice  using  laser  speckle  imaging  (LSI). 
Methods 
Transparent  stabilized-zirconia  cranial  implants 
Transparent  nanocrystalline  8  mol%  YO 1.5 yttria-stabilized  zirconia  (nc-YSZ) 
implant  samples  were  produced  as  explained  in  Chapter  2 63 .  The  thickness  of  the 
resulting  densified  YSZ  discs  were  reduced  from  1  mm  to  ~440  μm  by  polishing  with  30 
μm  diamond  slurry  on  an  automatic  polisher  (Pace  Technologies,  Tucson,  Arizona, 
USA).  The  samples  were  then  polished  with  successively  finer  diamond  and  silica 
slurries  ranging  from  6  to  0.2  μm.  Samples  were  sectioned  into  rectangles  of 
approximately  2.1  x  2.2  mm  using  a  diamond  lapping  saw  (WEIYI  DTQ-5,  Qingdao, 
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China),  followed  by  sonication  in  acetone  and  thorough  rinsing  in  water.  Optical, 
mechanical,  and  ageing  properties  of  the  material  were  reported  previously  38,63,74 . 
Animals 
N=12  C57BL/J6  WT  (# 000664 )  mice  were  obtained  from  Jackson  Laboratories. 
Animals  were  maintained  under  a  12-hour  light/dark  cycles  and  were  provided  food  and 
water ad  libitum .  All  experiments  were  performed  with  approval  from  the  University  of 
California  Animal  Care  and  Use  Committee  and  in  accordance  with  the  National  Institute 
of  Health  Animal  Care  and  Use  Guidelines.  Males  between  8  –  12  weeks  of  age  were 
used  in  this  study. 
Preoperative  surgical  preparation  and  anesthesia 
Mice  were  anesthetized  with  isoflurane  inhalation  (0.2-0.5%)  and  given  an  i.p. 
injection  of  ketamine  and  xylazine  (K/X)  (80/10  mg/kg).  Mice  were  aseptically  prepared 
for  surgery  and  secured  in  a  stereotaxic  apparatus.  Artificial  tear  ointment  was  applied  to 
the  eyes  to  prevent  drying.  Toe  pinch  reflex  was  used  to  measure  anesthetic  depth 
throughout  the  experiment,  and  supplemental  doses  of  K/X  were  administered  as  needed.  
Optical  clearing  agent 
A  mixture  of  two  biocompatible  chemicals,  PEG-400  (PEG)  and  Propylene 
Glycol  (PG)  (Fisher  Scientific,  California,  US),  were  used  as  scattering  reducer  and 
penetration  enhancer,  respectively,  at  a  volume  ratio  of  9:1  at  room  temperature 148,149 .  
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Ex  vivo  proof  of  concept:  optical  transmittance  measurements 
Scalp  and  skull  tissue  acquisition  and  preparation 
A  sagittal  incision  was  made  to  the  left  of  the  midline,  and  a  square  section  of  the 
scalp  was  excised.  Periosteum  was  removed  from  the  skull,  and  a  craniectomy  was 
performed  with  a  surgical  drill  and  carbide  burr  to  excise  a  square  section  of  skull  over 
the  right  parietal  lobe,  with  dimensions  of  2.6  x  2.6  mm.  Excised  full  thickness  scalp  and 
cranial  bone  from  above  the  right  parietal  lobe  were  rinsed  briefly  in  saline  solution  to 
remove  excess  blood.  The  thicknesses  of  the  samples  were  measured  to  be  440  ±  1μm, 
159  ±  1μm  and  710  ±  20μm  for  the  YSZ  implant,  the  mice  skull  and  scalp,  respectively. 
Hence,  the  YSZ  implant  is  2.5  times  thicker  than  the  mouse  skull.  Following  excision  of 
tissue,  mice  were  euthanized  by  intraperitoneal  (I.P.)  injection  of  pentobarbital  solution. 
Optical  transmittance  measurement  setup 
Optical  transmittance  measurements  of  the  different  samples  used  in  this  study 
were  obtained  through  optical  spectrometry.  The  setup  used  to  obtain  the  transmittance 
spectra  incorporates  two  multimode  optical  fibers  (P400-2-VIS-NIR,  Ocean  Optics,  FL) 
attached  to  individual  fiber  holders  including  visible-NIR  collimating  lenses  (MP-74-UV, 
Ocean  Optics,  FL,  with  focal  length  f  =  10mm,  lens  diameter  D  =  5mm  and  NA  =  D  /  2f 
=  0.4).  As  depicted  in  Figure  5.2(b),  the  holders  were  attached  to  a  mechanical  rail 
allowin0g  for  adjustment  of  the  distance  between  the  fibers  and  to  incorporate  a  sample 
holder.  After  the  sample  was  secured  within  the  holder,  the  fiber  holders  were  tightly 
joined  together  to  mitigate  detrimental  effects  from  ambient  light  and  back  reflections. 
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The  light  source  used  for  these  measurements  was  a  visible-NIR  source  (HL2000  FHSA, 
Ocean  Optics,  FL)  launched  into  one  of  the  optical  fibers.  The  beam  exiting  the  launching 
fiber  then  traverses  the  sample  and  is  collected  by  the  other  fiber,  which  is  connected  to  a 
solid-state  spectrometer  (SD2000,  Ocean  Optics,  FL)  to  obtain  the  optical  transmission 
spectra.  Spectra  were  acquired  averaging  10  measurements,  with  an  integration  time  of 
300  ms,  in  the  450-900  nm  wavelength  range.  For  all  the  measurements,  the  collimated 
transmittance  (T(λ))  was  calculated  as  the  ratio  of  light  transmitted  through  the  sample  to 
the  total  incident  light  (Equation  5.1).  Equation  6.1  shows  how  relative  change  in 
transmittance  was  calculated, 
elative transmittance change (%)R = T (λ) Reference
T (λ) T (λ) ∣ − Reference∣  (6.1) 
A  set  of  photographs  of  a  resolution  target  imaged  through  a  scalp  tissue  was  also 
captured  before  and  up  to  40  minutes  after  applying  the  OCA  using  a  metallurgical 
microscope  (MT  8530,  Meiji  Techno,  Japan).  
Experimental  design 
The  procedure  used  for  measuring  the  ballistic  transmittance  through  the  different 
tissues  and  the  implant  was  similar  to  procedures  reported  previously  for  spectroscopic 
measurements  on  soft  tissue 53,150,151 .  Three  sessions  of  measurements  were  performed.  In 
each  session,  optical  measurements  were  repeated  n=3  times  using  freshly  excited 
samples  from  3  new  mice.  All  of  the  samples  were  placed  between  two  glass  microscope 
coverslips  to  obtain  the  transmittance  spectra.  In  the  first  session,  scalp  and  skull  samples 
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were  excised  (from  Mice  1-3)  and  optical  transmittance  of  single  layer  samples  were 
measured  (Figure  6.1(a),  left  column).  After  obtaining  implant,  skull,  and  scalp  spectra,  a 
thin  layer  of  the  OCA  was  applied  on  the  scalp  and  the  optical  transmittance  of  optical 
cleared  scalp  (OCS)  was  measured  every  minute  over  a  50-minute  period 148,149 .  Stacking 
arrangements  were  then  used  for  the  second  and  third  sessions  of  measurements  allowing 
for  evaluating  the  effects  of  each  layer  on  the  spectral  features  of  the  sample.  This  further 
allows  for  comparing  the  spectral  features  of  the  skull  and  the  YSZ  implant  under  similar 
conditions.  In  the  second  session,  3  new  scalp  and  skull  samples  were  excised  (from  Mice 
4-6)  and  spectra  were  obtained  for  the  stacked  arrays  of  the  scalp  placed  on  top  of  the 
skull  (Figure  6.1(a),  middle  column).  Then,  the  OCA  was  applied  on  the  scalp  and 
samples  (OCS+skull)  were  measured  over  time.  In  the  third  session  of  measurements,  3 
new  scalp  samples  were  excised  (from  Mice  7-9)  and  the  stacked  array  of  the  scalp 
placed  on  top  of  the  implant  was  measured  (Figure  6.1(a),  right  column).  Then,  the  OCA 
was  applied  on  the  scalp  and  samples  (OCS+implant)  were  measured  over  time.  
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 Figure  6.1.  Optical  characterization  experimental  setups.  a)  Samples  used  in  the ex  vivo 
optical  characterization  including  single  layer  samples  of  skull,  scalp,  and  OCS  (left 
column);  stacked  sample  arrangement  of  scalp/OCS+skull  (middle  column);  and  stacked 
sample  arrangement  of  scalp/OCS+implant  (right  column).  b)  Collimated  transmittance 
measurements  setup.  The  inset  shows  the  housing  for  fixing  the  sample  placed  between 
coverslips. 
 
In  vivo  LSI  Imaging  of  Microvasculature 
Mouse  model  preparation 
The  mouse  model  for  this  study  was  designed  to  provide  optical  access  to  the 
right  parietal  lobe  of  the  brain  through  the  OCS  and  WttB  implant  (Figure  6.2(a)).  A 
sagittal  incision  was  made  to  the  left  of  the  midline,  and  the  scalp  retracted  to  expose  the 
skull  (Figure  6.2(a)).  Periosteum  was  removed  from  the  skull,  and  a  craniectomy  was 
performed  with  a  surgical  drill  and  carbide  burr  to  remove  a  square  section  of  skull  over 
the  right  parietal  lobe,  with  dimensions  slightly  larger  than  the  implant  (Figure  6.2(a), 
inset  I  and  II).  The  YSZ  implant  was  placed  within  the  craniectomy  directly  on  the  intact 
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dura  mater ,  and  dental  cement  was  applied  to  each  of  the  four  corners  of  the  implant  to 
prevent  displacement  (Figure  6.2(a),  inset  III).  Dental  cement  was  cured  with  blue  light 
exposure  for  20  seconds.  Imaging  with  LSI  was  conducted  before  and  after  opening  the 
scalp  (imaging  conditions  1  and  2,  respectively),  immediately  after  the  craniectomy 
procedure,  while  the  scalp  was  still  open  (imaging  condition  3),  and  after  the 
implantation  (imaging  condition  4).  Then,  the  retracted  scalp  was  placed  back  over  the 
implant  and  a  ring-shape  barrier  (for  holding  OCA)  was  made  on  top  of  the  scalp  using 
dental  cement  and  cured  with  blue  light  (Figure  6.2(a),  inset  IV).  LSI  imaging  was 
conducted  before  and  immediately  after  carefully  adding  a  drop  of  OCA  inside  the  dental 
cement  holder  (imaging  conditions  5  and  6,  respectively). 
Laser  speckle  imaging  setup 
For  LSI,  an  810  nm  continuous  wave  NIR  laser  (DL808-7W0-O,  CrystaLaser, 
Reno,  NV,  USA)  was  used  to  illuminate  the  region  of  interest  with  an  incident  power  of 
100  mW  at  a  45°  incidence.  While  most  LSI  studies  use  visible  wavelengths  for 
illumination,  we  chose  810  nm  to  reduce  reflectance  and  increase  transmittance  through 
the  WttB  implant 24 .  The  810  nm  laser  was  expanded  using  a  pair  of  negative-positive 
lenses  (KPC043,  −25  mm  EFL  and  KPX094,  100  mm  EFL,  Newport,  Irvine,  CA,  USA) 
and  speckles  were  generated  and  homogenized  using  an  engineered  diffuser 
(ED1-C20-MD,  Thorlabs,  Newton,  NJ,  USA).  Diffused  laser  light  was  shown  onto  the 
intact  scalp  (i.e.  condition  1),  onto  the  intact  skull  (i.e.  condition  2),  onto  the  dura  mater 
and  cortex  after  craniectomy  (i.e.  condition  3),  through  the  WttB  implant  (i.e.  condition 
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4),  onto  the  closed  scalp  (i.e.  condition  5),  and  onto  the  closed  scalp  after  applying  the 
OCA  (i.e.  condition  6).  The  crossed  polarized  (LPVIS100,  Thorlabs,  Newton,  NJ,  USA) 
reflected  light  from  the  illuminated  region  was  captured  by  a  12-bit  CMOS  camera 
(DCC1545M,  Thorlabs,  Newton,  NJ,  USA)  equipped  with  a  10X  zoom  microscope 
(MLH-10X,  152.4  mm  WD,  Computar,  Torrance,  CA,  USA).  The  aperture  and 
magnification  of  the  zoom  microscope  were  carefully  chosen  to  ensure  that  the  speckle 
size  at  the  image  plane  was  approximate  to  the  area  of  two  pixels  in  the  CMOS  chip.  A 
schematic  of  the  imaging  system  is  shown  in  Fig ure  6.2(b).  For  each  imaging  condition,  a 
sequence  of  100  laser  speckle  images  were  captured  at  exposure  time  of  6ms  (per  our 
previous  report  on  optimized  LSI  exposure  time) 24  at  a  speed  of  14  frames  per  second.  
Then,  the  laser  speckle  images  were  analyzed  to  obtain  the  contrast  image. 
Image  processing  and  data  analysis 
The  contrast-resolved  LSI  images  were  constructed  based  on  temporal  statistical 
analysis  of  laser  speckle  which  has  been  proven  to  preserve  spatial  resolution 114 . 
Experimental  results  have  indicated  that  temporal  speckle  contrast  analysis  could 
expressively  suppress  the  effect  of  the  static  laser  speckle  pattern  formed  by  the 
stationary  superficial  reflection  and  scattering  tissue  on  the  visualization  of  blood  flow 
108,114,152 .  Suppressing  this  effect  makes  temporal  contrast  analysis  an  ideal  method  for 
imaging  cerebral  blood  flow,  and  in  this  study  we  assess  whether  this  method  can  resolve 
blood  flow  across  the  skull,  scalp,  OCS,  and  implant.  The  temporal  contrast, K t ,  of  each 
image  pixel  in  the  time  sequence  was  calculated  using  Equation  (6.2)  108 , 
91  
  (6.2) 
 
where I x,y (n)  is  the  CMOS  counts  at  pixel  (x,y)  in  the  nth  image,  N  is  the  number  of 
images  acquired,  and 〈I x,y 〉  is  the  mean  value  of  CMOS  counts  at  pixel  (x,y)  over  the  N 
images.  The  raw  images  were  process  to  obtain  the  contrast  image.  The  contrast  images 
across  the  height  positions  were  compared  to  find  the  correctly  focused  plane  (associated 
with  the  highest  contrast)  for  each  imaging  condition. 
We  assessed  the  quality  of  the  speckle  contrast  images  over  the  imaging 
conditions in  terms  of  signal-to-noise  ratio  (SNR)  and  vessel sharpness.  To  quantify 
signal  to  noise  ratio  for  each  imaging  condition,  the  contrast  intensity  profile  along  a 
vertical  line  (across  the  blood  vessels)  was  considered.  To  avoid  selection  bias,  the 
location  of  these  line  profiles  were  chosen  arbitrarily  at  the  region  of  interest  (ROI) 
mid-points.  The  midlines  intersected  3  to  4  vessels,  and  remained  the  same  between  the 
imaging  conditions.  Equation  (6.3)  shows  how  SNR  values  were  calculated  for  each 
imaging  condition, 
 (6.3) 
where ΔK  is  the  depth  of  the  vessel  peak  from  the  baseline  (mean  noise)  and σK n  is  the  
standard  deviation  of  the  noise.  The  SNR  values  were  averaged  over  the  mice  (10,  11, 
and  12)  and  standard  error  (SE)  were  calculated.  Sensitivity,  which  is  considered  as  the 
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ratio  of  the  mean  SNR  to  the  mean  SNR  of  the  reference,  was  calculated  using  Equation 
(6.4).  
   (6.4) 
As  an  indicator  of  resolution,  we  compared  the  sharpness  of  the  vessel  edges  in 
images  by  calculating  fall  distance  (the  number  of  pixels  multiplied  by  the  pixel  size  (~3 
μm ))  of  the  edge  of  the  vessel  to  go  from  10%  to  90%  of ΔK  value 131 .  A  shorter  fall 
distance  corresponds  to  greater  sharpness.  The  same  sampled  contrast  intensity  profile 
lines  were  considered  for  the  fall  distance  calculation.  To  consider  the  vessel  sizes  while 
comparing  SNR  and  fall  distance, full-width  half-max  (FWHM)  of  the  vessels  in  profiles 
were  taken  as  the  vessel  diameter  153 . 
Experimental  design 
A  session  of in  vivo brain  imaging  using  LSI  was  performed  on  3  new  mice 
(referred  to  hereafter  as  Mice  10-12)  (Figure  6.2(a)). In  vivo  LSI  through  the  six  imaging 
conditions  of  intact  scalp  (i.e.  condition  1),  intact  skull  (i.e.  condition  2),  direct-brain  (i.e. 
condition  3),  implant  (i.e.  condition  4),  scalp+implant  (i.e.  condition  5),  and 
OCS+implant  (i.e.  condition  6)  were  performed  in  succession  in  each  of  the  mice  (n=3).  
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 Figure  6.2.  a)  The  mouse  model  used  for  LSI in  vivo  imaging.  In  the  inset,  a  schematic 
of  the  mouse  head  illustrating  the  location  of  the  optical  access  is  shown.  Surgical 
preparation  steps  including  retracted  scalp  to  expose  the  skull  (I),  craniotomy  and 
implantation  (II,  III),  and  replacing  the  scalp  and  making  a  ring-shaped  OCA  holder  (IV) 
are  also  shown  in  the  inset  (scale  bars  =  4  mm).   b)  Experimental  imaging  setup.  
 
Statistical  analysis 
Data  from ex  vivo  optical  transmittance  measurements  and in  vivo  imaging  were 
expressed  as  mean  and  SE  and  tested  statistically  by  a  two-sided  t-test  through  the 
software  Origin  2018  for  Windows.  The  significance  level  was  set  at  p < 0.05. 
Results 
Ex  vivo  proof  of  concept:  optical  transmittance  measurements 
Figure  6.3(a)  illustrates  the  spectrotemporal  effect  of  OCA  on  scalp.  Absolute 
change  in  the  optical  transmittance  spectra  (referenced  to  baseline  before  applying  OCA) 
for  up  to  50  minutes  after  applying  OCA  is  shown  in  Figure  6.3(a).  A  primary  change  in 
optical  transmittance  is  noticeable  immediately  upon  applying  the  OCA  (minute-0).  A 
sudden  significant  increase  then  occurs  after  10  minutes  (p  <  0.02342  in  450-900  nm) 
which  then  gradually  decreases.  The  curved  black  lines  on  the  3D  figure  depict 
transparency  increases  by  3.5%.  A  maximum  optical  transmittance  of  90%  (41%  increase 
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above  baseline  values)  was  obtained  after  11  minutes  from  applying  OCA  for  the 
wavelength  of  889  nm.  The  upper  2D  map  in  the  figure  also  reflects  the  spectrotemporal 
behavior  of  OCS,  showing  the  ideal  time  to  optically  access  the  brain  across  the  OCS.  As 
an  example,  the  dashed  line  represents  the  temporal  change  at  a  wavelength  of  810  nm 
(the  wavelength  used  for in  vivo  LSI).  A  time-window  of  ~13  minutes  for  using  the  OCS 
was  evaluated,  in  which  the  OCS  transparency  (at  810  nm)  is  ~36%  higher  than  the 
untreated  scalp  tissue  (p  <  0.05)  (Figure  6.3(b)).  The  top  3%  of  optical  transmittance 
improvement  was  achieved  within  minutes  5  to  18  after  applying  OCA,  associated  with 
an  absolute  change  from  33%  up  to  36%.  Figure  6.3(c)  shows  the  temporal  change  in 
optical  properties  of  the  scalp  tissue  from  the  moment  OCA  was  applied  (minute-0)  up  to 
40  minutes  after  application.  A  higher  light  transmission  and  transparency  is  noticeable  at 
minute-10  which  gradually  decreases  with  time.  
 
 
Figure  6.3.  Temporal  effect  of  OCA  on  scalp.  a)  Spectrotemporal  behavior  of  OCS, 
absolute  change  in  optical  transmittance  is  shown  versus  wavelength  and  time.  b) 
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Temporal  change  in  optical  transmittance  at  a  wavelength  of  810  nm  (mean  and  SE 
values).  A  time-window  of  13  minutes  is  augmented  to  the  plot  showing  the  duration  of 
time  transmittance  is  highest  in  the  OCS.  c)  Visual  comparison  of  photographs  of  a 
resolution  target  captured  through  scalp  tissue  before,  immediately  after  (minute-0),  and 
up  to  40  minutes  after  applying  OCA.  The  distance  between  the  lines  in  the  target  is  ~150 
μm. 
 
A  set  of  photographs  of  an  NBS  1963A  resolution  target  imaged  through  the 
implant,  skull,  and  scalp  provides  a  visual  comparison  of  the  light  transmittance  and 
image  quality  over  the  samples  (Figure  6.4(a)).  Optical  transmittance  of  skin,  skull,  and 
implant  are  shown  in  Figure  6.4(b).  All  three  of  the  scalp,  skull,  and  implant  show  an 
increasing  trend  in  transmittance  as  the  wavelength  increases.  The  implant  has  higher 
optical  transmittance  compared  to  the  skull  in  the  range  of  450-890  nm  (significantly 
higher  in  450-815  nm,  p  <  0.05).  In  the  range  of  525  -  600  nm,  skull  shows  a  drop  in  the 
transmittance  which  was  not  observed  in  the  implant  spectra.  The  same  change  in  the 
slope  at  525  -  600  nm,  appeared  in  the  scalp  tissue  as  well.  A  comparison  between  the 
mouse  scalp  and  skull  optical  transmittance  shows  that  optical  extinction  by  the  scalp  is 
notably  higher  than  that  of  the  skull  (p  <  0.05  in  450-900  nm),  revealing  that  the  scalp  is 
the  primary  limiting  factor  here.  The  optimum  effect  of  OCA  was  considered  for  the 
comparisons  in  Figure  6.4(c-f)).  Figure  6.4(c)  shows  a  significant  relative  increase  of 
100%  (gray  dashed  line)  in  optical  transmittance  at  450  nm  in  OCS  (p  =  0.0209)  which 
gradually  decreased  to  41%  at  889  nm  (p  =  0.0061).  Optical  transmittance  of  the 
scalp+skull  stack  is  shown  in  Figure  6.4(d)  (dark  green  line).  As  expected,  it  resulted  in  a 
similar  optical  transmittance  to  the  scalp  (limited  by  the  high  optical  extinction  in  the 
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scalp).  OCS+skull  optical  transmittance  showed  a  relative  increased  (gray  line)  of  61% 
(at  450  nm)  and  46%  (at  889  nm).  The  scalp+implant  stack  also  has  a  similar  optical 
behavior  to  the  scalp  alone  (Figure  6.4(e)).  A  significant  relative  increase  of  270%  at  450 
nm  (p  =  0.02547)  was  obtained  by  OCS+implant.  Maximum  optical  transmittance  of 
89%  was  obtained  at  889  nm  which  is  77%  relatively  higher  compared  to  scalp+implant 
(p  =  0.0003).  Figure  6.4(f)  compares  light  transmission  through  OCS+implant  and 
scalp+skull.  The  bars  show  the  maximum  optical  transmission  of  OCS+implant  in 
various  wavelength  ranges  including  89%  in  NIR  range  (700-900  nm),  50%  in  red  range 
(565-700  nm),  24%  in  green  range  (485-565  nm),  and  20%  in  blue  range  (450-485  nm). 
A  maximum  relative  change  of  151%  (at  450  nm)  in  the  optical  transmittance  was 
obtained  using  OCS+implant  compared  to  scalp+skull  (p  =  0.0043). 
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 Figure  6.4.  a)  Visual  comparison  of  light  transmission  using  photographs  of  an  NBS 
1963A  resolution  target  through  the  WttB  implant,  skull,  and  scalp.  The  resolutions 
shown  are  the  18  cycle/mm  target  (each  black  line  width  is  27.78  μm).  b)  Optical 
transmittance  of  scalp,  skull,  and  implant.  c)  Comparison  of  optical  transmittance  through 
scalp  and  OCS.  d-f)  Comparison  of  the  effect  of  optical  clearing  on  optical  transmittance 
of  the  tissue  sample  stacks;  d)  scalp+skull  vs.  OCS+skull,  e)  scalp+implant  vs. 
OCS+implant,  f)  scalp+skull  vs.  OCS+implant. 
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In  vivo  LSI  Imaging  of  Microvasculature 
The  results  from in  vivo  LSI  imaging  are  shown  in  Figure  6.5,  6.6,  and  6.7.  Figure 
6.5(a)  shows  regular  images  (showing  the  LSI  field  of  view)  and  LSI  contrast  images  at 
each  imaging  condition  for  Mouse  10  (data  for  Mice  11-12  not  shown).  Line  intensity 
profiles  were  analyzed  for  the  intact  scalp  (i.e.  condition  1),  intact  skull  (i.e.  condition  2), 
direct-brain  (i.e.  condition  3),  implant  (i.e.  condition  4),  scalp+implant  (i.e.  condition  5), 
and  OCS+implant  (i.e.  condition  6)  contrast  images.  To  avoid  selection  bias,  the  location 
of  these  line  profiles  were  chosen  arbitrarily  at  the  ROI  mid-points,  as  depicted  in  the  LSI 
images  in  Figure  6.5(a).  The  midlines  intersected  3  to  4  vessels  like  the  example  shown 
with  arrows  in  Figure  6.5(b)  for  Mouse  10.  From  these  intensity  profiles,  peak  intensity 
and  noise ( ΔK  and  σK n )  values were  determined  (as  described  in  the  Methods  section  and 
illustrated  in  the  inset  of  Figure  6.5(b)).  Then  SNR  and  fall  distance  were  calculated  (see 
Fig ure  6.5(b)  for  an  example  trace  with  the  10–90%  fall  distance  measurement 
illustrated ).  The  scalp  and  scalp+implant  did  not  visualize  any  vessels  which  could  be 
considered  for  comparing  SNR,  sensitivity,  and  fall  distance. 
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 Figure  6.5. In  vivo brain  microcirculation  images  over  the  imaging  conditions.  a)  The  left 
column  presents  the  schematics  of  the  imaging  conditions  1-6,  with  the  blue  tetragonals 
representing  the  imaging  fields  of  view  on  murine  cranium.  The  middle  column  shows 
regular  images  of  the  ROI  which  remain  the  same  over  the  imaging  conditions.  The 
corresponding  LSI  temporal  contrast  images  for  6  imaging  conditions  of  Mouse  10  were 
shown  in  the  right  column.  The  dashed  lines  show  the  consistent  location  along  the 
midline  of  ROI  where  line  profiles  were  taken.  b)  Example  contrast  intensity  profiles  in 
imaging  conditions  of  1-6.  The  arrows  in  b)  show  the  vessels  that  are  intersected  by  the 
midline  intensity  profiles.  Scale  bars  =  1  mm. 
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Data  for  each  imaging  condition  was  averaged  between  the  vessels  and  the  mean 
SNR  for  each  imaging  condition  is  shown  in  Figure  6.6(a).  As  shown  in  the  Figure,  the 
direct-brain  gave  the  highest  SNR,  and  implant,  intact  skull,  and  OCS+implant  have 
lower  SNR  values  respectively;  while  the  intact  scalp  and  scalp+implant  did  not  show 
detectable  vessels.  Figure  6.6(b)  shows  a  plot  of  vessels  intersected  by  the  profile  line 
across  the  imaging  conditions,  with  SNR  plotted  against  FWHM  (i.e.  vessel  diameter). 
Next,  using  the  15  LSI  temporal  contrast  images  corresponding  to  these  imaging 
conditions  for  Mice  10-12,  we  sought  to  compare  the  sharpness  (i.e.  fall  distance)  of  the 
vessels  in  the  images  to  compare  the  image  resolution.  Values  for  each  imaging  condition 
were  averaged  between  the  vessels  and  the  mean  fall  distance  for  each  imaging  condition 
is  shown  in  Figure  6.6(c).  Direct  brain  provided  the  lowest  fall  distance  (highest 
sharpness)  and  intact  skull  resulted  in  the  highest  fall  distance  (lowest  sharpness). 
OCS+implant  showed  slightly  higher  fall  distance  than  implant  alone  (p  =  0.6721).  A  plot 
of  all  vessels  intersected  by  the  profile  line,  with  fall  distance  (i.e.  vessel  sharpness) 
plotted  against  FWHM  (i.e.  vessel  diameter)  is  shown  in  Figure  6.6(d). 
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 Figure  6.6. Comparison  of  LSI  image  quality  over  the  imaging  conditions.  a)  Mean  SNR 
of  contrast  intensity  along  midline  profiles  on  the  imaging  conditions.  b)  SNR  vs  FWHM 
for  all  vessels  intersected  by  line  profiles.  c)  Mean  fall  distance  along  the  line  profiles 
over  the  imaging  conditions.  d)  Fall  Distance  vs  FWHM  for  all  vessels  intersected.  Error 
bars  represent  standard  error. 
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Considering  the  temporal  effect  of  OCA  on  scalp  tissue  optical  transparency,  we 
sought  to  quantitatively  evaluate  this  effect  on  the  LSI  imaging  quality.  Figure  6.7(a) 
shows  LSI  images  of  OCS+implant  (imaging  condition  6)  immediately  after  and  up  to  40 
minutes  after  applying  the  OCA  for  Mouse  10  (data  for  Mice  11-12  not  shown).  The  LSI 
images  visually  show  the  temporal  change  in  scalp  transparency.  Line  intensity  profiles 
like  the  example  shown  in  Figure  6.5(a)  and  6.5(b)  were  analyzed  to  determine  peak 
intensity  and  noise  to  calculate  SNR  and  fall  distance.  Data  for  each  time  point  (minutes 
0,  10,  20,  30,  and  40)  was  averaged  between  the  vessels  and  the  mean  SNR  for  each  time 
point  after  applying  OCA  (imaging  condition  6)  is  shown  in  Figure  6.7(b).  The  minute-10 
contrast  image  shows  the  highest  SNR  (p  <  0.05)  (imaging  condition  6)  which  then 
gradually  decreases  at  minutes  20  and  30  and  approximately  equals  to  the  initial  value 
(minute-0)  at  minute-40.  Figure  6.7(c)  shows  a  plot  of  vessels  intersected  by  the  profile 
line  across  the  imaging  conditions,  with  SNR  plotted  against  FWHM  (i.e.  vessel 
diameter).  Alongside,  using  the  15  LSI  images  corresponding  to  these  time  points  for 
Mice  10-12,  we  compared  the  sharpness  (i.e.  fall  distance)  of  the  vessels  in  the  images  to 
compare  the  image  resolution.  Fall  distances  for  each  imaging  time  point  were  averaged 
between  the  vessels  and  the  mean  fall  distance  is  shown  in  Figure  6.7(d).  A  plot  of  all 
vessels  intersected  by  the  profile  line,  with  fall  distance  (i.e.  vessel  sharpness)  plotted 
against  FWHM  (i.e.  vessel  diameter)  is  shown  in  Figure  6.7(e). 
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 Figure  6.7. a) In  vivo brain  microcirculation  LSI  images  of  OCS+implant  (imaging 
condition  6)  immediately  after  and  up  to  40  minutes  after  applying  the  OCA.  LSI  images 
show  the  arbitrary  locations  where  line  profiles  along  the  midline  of  ROI  were  taken. 
Scale  bars  =  1  mm.  b-e)  Comparison  of  LSI  image  quality  of  OCS+implant  (imaging 
condition  6).  Mean  SNR  of  contrast  intensity  along  line  profiles  on  LSI  images  (Imaging 
condition  6)  immediately  after  and  up  to  40  minutes  after  applying  the  OCA  (b).  SNR  vs 
FWHM  for  all  vessels  intersected  by  line  profiles  (c).  Mean  fall  distance  along  the  line 
profiles  over  the  time  points  (d).  Fall  Distance  vs  FWHM  for  all  vessels  intersected.  Error 
bars  represent  standard  error  (e). 
 
 
 
 
 
 
 
 
 
 
 
104  
Discussion 
The  application  of  transparent  cranial  implants  coupled  with  scalp  optical  clearing 
holds  the  transformative  potential  for  facilitating  the  diagnosis  and  treatment  of  a  wide 
variety  of  brain  pathologies  and  neurological  disorders.  PEG,  reported  as  a  biocompatible 
OCA,  has  been  widely  used  in  various  applications  such  as  dermal  blood  flow  imaging 
124,149,154,155 .  Although  the  effect  of  this  OCA  diminishes  10-20  minutes  after  the 
application,  the  optical  access  can  be  obtained  repeatedly  and  chronically 124,155 .  In  this 
pilot  study,  we  assessed  the  light  delivery  improvement  by  WttB  implant  coupled  with 
OCS  in  a  set  of ex  vivo optical  characterization  measurements.  Additionally,  we  evaluated 
the  feasibility  of  through-scalp  brain  microcirculation  imaging in  vivo .  There  are  several 
limitations  to  the  current  study.  The  sample  sizes  used  were  small  (n  =  3),  and  further 
experiments  are  needed  to  confirm  the  reproducibility  of  these  findings.  While  our 
proposed  approach  can  allow  for  noninvasive  imaging  of  the  brain  at  later  time  points,  it 
requires  an  initial  implantation  surgery  which  carries  associated  risks  such  as  infection. 
Ex  vivo  proof  of  concept:  optical  transmittance  measurements 
The  scalp  optical  clearing  results,  shown  in  Figure  6.3  and  Figure  6.4(c),  were  in 
agreement  with  the  previous  reports  of  using  PG-PEG  agent 142–144 .  More  effective  OCAs 
have  been  introduced  recently  and  although  they  have  shown  higher  transparency,  they 
have  not  been  widely  accessible  and  used 148 .  The  optimum  effect  resulted  within  10-20 
minutes  after  OCA  application.  The  maximum  optical  transmission  was  obtained  at 
minute-11  and  wavelength  of  889  nm.  OCA  provided  13  minutes  of  transparency  in  the 
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highest  zone  (33%  -  36%  increase  in  transparency)  for  wavelengths  in  the  range  of 
800-900  nm.  Since  our  optical  measurements  are  based  on  collimated  light  transmittance 
we  can  not  directly  compare  our  results  to  the  previous  works.  Therefore,  our  results  were 
used  to  relatively  compare  optical  transmittance  values  in  the  difference  conditions.  In 
Figure  6.4(a),  the  implant  appears  as  a  shade  of  orange  indicating  its  higher  light 
transmission  in  longer  wavelengths.  This  nc-YSZ  implant  can  be  also  optimized  for 
various  wavelength  ranges 74 .  The  skull  tissue  transmits  the  light,  although  the  texture  of 
the  cranial  bone  notably  decreases  the  spatial  resolution.  The  pristine  scalp  tissue  has  a 
very  low  light  transmission  and  does  not  visualize  the  resolution  target.  It  should  also  be 
noted  that  while  the  optical  transmittance  of  the  implant  is  an  improvement  over  the 
skull,  shown  in  Figure  6.4(a)  and  6.4(b),  the  mouse  skull  is  inherently  transparent  itself 
114 ,  which  is  not  the  case  in  larger  animals  or  humans.  The  hemoglobin  optical  absorbance 
signature  (520-620  nm)  in  scalp  and  skull  tissues  limiting  the  access  in  that  wavelength 
range 54,156,157  is  significantly  improved  through  OCS+implant.  In  Figure  6.4(f),  relative  
increase  in  transmittance  (gray  line)  of  up  to  151%  in  blue  (450-485  nm),  75%  in  green 
(485-565  nm),  55%  in  red  (565-700  nm),  and  99%  in  NIR  (700-900  nm)  wavelength 
ranges  obtained  through  OCS+implant  compared  to  scalp+skull.  This  shows  promising 
features  to  facilitate  various  photosensitizer  activation-based  therapies. 
Photobiomodulation  (600-1064  nm) 1,2,57–59 ,  PDT(405-900  nm,  mainly  in  red  range) 4,60 , 
optogenetic  (400-630  nm) 5,9,61  are  a  few  examples  of  optical  techniques  that  could  benefit  
from  the  improved  light  delivery  offered  by  WttB  implant  and  scalp  optical  clearing. 
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In  vivo  LSI  Imaging  of  Microvasculature 
It  should  be  mentioned  that  blood  flow  is  expected  to  be  altered  in  response  to  the 
invasive  cranioplasty  surgery  (e.g.  due  to  potential  reactive  hyperemia 133 ,  changes  in 
respiration,  and  anesthesia  depth). 
The  direct-brain  image  had  the  highest  average  SNR  of  5.25.  As  the  size  of 
vessels  and  velocity  of  blood  flow  is  not  expected  to  differ  on  average  between  the 
imaging  conditions,  the  apparent  increase  in  SNR  and  vessel  diameter  imaged  through 
the  scalp,  skull,  implant,  and  OCS+implant  is  likely  due  to  the  blurring  of  the  image. 
OCS+implant  showed  SNR  of  4.25  and  Sensitivity  of  81%  while  intact  scalp  images  did 
not  show  any  detectable  vessels.  Implant  and  intact  skull  images  had  SNR  values  of  5.08 
and  4.45,  respectively  (p  =  0.0047).  Imaging  sensitivities  for  implant  and  intact  skull 
were,  respectively,  96%  and  84%.  In  Figure  6.6(a),  implant  image  vessels  showed  a 
similar  pattern  to  the  direct-brain  vessels  although  they  are  slightly  shifted  toward  lower 
SNR  and  higher  size.  
The  OCS+implant  showed  fall  distance  of  11μm  (see  Figure  6.6(c))  while  intact 
scalp  did  not  visualize  any  brain  vessels.  The  implant  images  had  a  lower  fall  distance  of 
9.6  μm  (sharper  image)  compared  to  intact  skull  image  with  fall  distance  of  15.3  μm  (P  < 
0.001).  The  skull  and  OCS  scattering  both  disorder  the  speckle  pattern  that  was  created 
by  the  brain  hemodynamics.  The  reduction  in  border  sharpness  of  the  vessels  imaged 
through  the  intact  skull  vs  OCS+implant  suggests  that  the  skull  has  a  higher  blurring 
effect  as  seen  in  Figure  6.5(a)  and  Figure  6.6(c).  The  direct-brain  images  with  fall 
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distance  of  8.2  μm  showed  the  highest  vessel  sharpness  (p  <  0.05).  In  Figure  6.6(d),  the 
data  from  OCS+implant,  implant,  and  direct-brain  fell  into  a  similar  cluster  placed  mostly 
in  the  lower  left  quadrant  associated  with  lower  vessel  size  and  higher  sharpness.  On  the 
other  hand,  a  half  of  intact  skull  vessels  were  detected  in  the  high  vessel  size  and  low 
sharpness  quadrant. 
In  Figure  6.7(b),  the  change  in  SNR  values  from  minute-0  to  minutes-40  is  in 
agreement  with ex  vivo  optical  transmittance  measurements  (Figure  6.3(b,c))  and  also 
previous  studies  on  LSI  and  OCAs 124,158 .  In  Figure  6.7(c),  the  vessels  at  minutes  10,  20, 
and  30  fell  in  the  smaller  vessel  size  quadrants  (left  half)  covering  both  lower  and  higher 
SNR  quadrants.  On  the  other  hand,  the  vessel  at  minutes  0  and  40  mostly  fell  in  the  lower 
SNR  quadrants  (lower  half)  including  the  smaller  and  larger  vessel  size  quadrants.  This 
suggests  that  within  the  time  points  with  higher  effect  of  OCA  (minutes  10,  20,  30),  the 
effect  on  detected  vessel  size  is  more  obvious  than  the  effect  on  the  SNR  value.  In  Figure 
8(d),  a  significant  increased  sharpness  is  visible  in  minute-10  (p  <  0.05).  Additionally,  the 
separated  clusters  of  imaged  vessels  at  minutes  10  and  20  in  Figure  6.7(e)  fell  in  the 
lower  size  and  higher  sharpness  suggests  that  the  OCA  effect  is  more  noticeable  in 
sharpness  (resolution)  of  the  image  than  SNR. 
Microcirculation  plays  a  critical  role  in  physiological  processes  such  as  tissue 
oxygenation  and  nutritional  exchange 11,159 .  Monitoring  the  spatiotemporal  characteristics 
of  microcirculation  is  crucial  for  studying  the  normal  and  pathophysiologic  conditions  of 
tissue  metabolism.  For  example,  microcirculation  monitoring  is  useful  for  assessing 
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microcirculatory  dysfunction  due  to  disease  conditions  such  as  type  2  diabetes,  peripheral 
vascular  disease  (PVD),  atherosclerotic  coronary  artery  disease,  obesity,  heart  failure, 
Alzheimer’s,  schizophrenia  and  hypertension,  among  others 139,160,161 .  In  addition, 
quantification  of  dynamic  blood  flow,  angiogenesis,  and  vessel  density  are  critical  for 
monitoring  the  progression  of  wound  healing 140 .  Although  high-resolution  vascular 
network  mapping  is  possible  using  imaging  modalities  such  as  computed  tomography 
(CT),  these  approaches  require  injection  of  contrast  agents  and  pose  disadvantages  such 
as  radiation  exposure.  Existing  non-invasive  methodologies  (including  LSI  through  skull) 
are  inadequate  to  study  brain  blood  flow  at  microvessel  resolution 122 .  To  the  best  of  our 
knowledge  there  have  been  no  report  of  through-scalp  brain  microcirculation  optical 
imaging.  Optical  accesses  such  as  OCS  coupled  with  WttB  implant  are  thus  important 
tools  for  research  and  can  become  important  enablers  of  clinical  diagnostics  and  therapy 
involving  cerebral  microvessels.  Figure  6.8  visually  illustrates  the  enhancement  in 
optically  accessing  the  brain  microcirculation  through  OCS+implant.  An  example  region 
in  the  flowmetric  image  shown  with  dashed  line  was  compared  to  direct-brain  and  intact 
scalp  images.  The  vessel  intersected  by  the  black  line  (V1)  has  a  width  of  22.5  μm  and 
the  vessel  intersected  by  the  purple  line  (V2)  has  a  width  of  16.8  μm.  Precise  velocity 
information,  particularly  of  microvessels,  appeared  through  the  OCS+implant,  while  the 
inhibited  signal  through  intact  scalp  and  skull  obscures  flow  determinations. 
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 Figure  6.8.  A  regular  image  of  Mouse  10  head  showing  the  provided  brain 
flowmetric  imaged  obtain  through  scalp.  The  implanted  WttB  prosthesis  and  a 
drop  of  OCA  on  the  closed  scalp  was  able  to  provide  access  to  the  brain 
microcirculation.  An  example  region  in  the  flowmetric  image  (shown  with  dashed 
line)  was  compared  to  the  reference  (direct-brain)  and  intact  scalp  images.  The 
vessel  intersected  by  the  black  line  (V1)  has  a  width  of  22.5  μm  and  the  vessel 
intersected  by  the  purple  line  (V2)  has  a  width  of  16.8  μm.  Scale  bar  =  500  μm. 
 
Creating  novel  windows  for  brain  studies  has  been  gaining  attention  recently 
35,162–164 .  Some  of  these  studies,  involving  OCAs  applied  to  the  scalp  overlying  native 
skull,  have  shown  limited  success  due  to  optical  losses  and  scattering  in  the  skull 32 . 
Future  studies  by  our  group  will  explore  this  combined  OCA-WttB  strategy  for  chronic 
imaging  in  awake  and  behaving  animals  through  closed  scalp,  to  study  cerebrovascular 
hemodynamic  responses  to  a  photoactivation  stimulation. 
In  this  study,  a  through-scalp  optical  access  to  the  brain  in  wavelength  range  of 
blue  to  NIR  (450-900nm)  was  reported.  Application  of  a  transparent  cranial  implant  and 
optical  clearing  of  the  scalp  shows  promising  features  to  facilitate  various  photosensitizer 
activation-based  therapies.  Additionally,  transmittance  peaked  at  89%  at  810  nm  allowed 
for  laser  speckle  imaging  of  brain  microcirculation.  Strategies  for  providing 
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through-scalp  optical  access  to  the  brain  without  repeated  craniectomy  and/or  scalp 
retraction,  like  the  one  presented  in  this  chapter,  could  one  day  improve  clinical  imaging 
and  optical  diagnosis  and  treatment  of  brain  diseases  without  the  need  for  repeated 
craniectomy  or  retraction  of  the  scalp  . 
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Chapter  7.  Conclusions  and  Recommendations  for  Future  work 
In  this  dissertation,  I  illustrated  that  transparency  of  WttB  implant  provides  an 
excellent  opportunity  for  light-based  theranostics  since  light  could  be  easily  transmitted 
through  it  without  undergoing  excessive  attenuation.  In  addition,  transmission  of  visible 
and  near  infrared  light  through  transparent  cranial  implants  would  not  only  open  a 
“window”  through  which  detailed  brain  features  could  be  imaged  and  deep  targets  could 
be  therapeutically  treated,  but  would  also  facilitate  through-scalp  prolonged 
post-operatory  interventions. 
The  feasibility  of  long  term  application  of  nc-YSZ  implants  with  various  dopant 
levels  was  demonstrated  in  this  dissertation.  In  chapter  2,  I  showed  WttB  implant  can 
withstand  extended  accelerated  ageing  tests  and  preserve  its  excellent  optical  and 
mechanical  properties.  Then,  this  implant  was  applied  for  chronic  brain  imaging  on  mice. 
In  chapter  3,  image  quality  stability  up  to  60  days  post-implantation  was  shown.  Since 
WttB  implant  allows  light  transmission  for  a  wide  range  of  wavelengths,  I  developed  and 
applied  a  multispectral  imaging  coupled  with  LSI.  This  study,  demonstrated  in  chapter  4, 
showed  arteriovenous  imaging  of  brain  microvessels  through  WttB  implant  is  possible 
and  visuals  a  unique  vascule  map  which  is  not  possible  through  intact  skull.  Since  WttB 
cranial  implant  is  developed  to  provide  optical  access  for  post-operative  theranostic 
purposes  without  scalp  removal,  in  Chapters  5  and  6  I  illustrated  the  use  of  an  optical 
clearing  agent  (OCA)  in  the  scalp  of  mice  to  provide  a  through-scalp  optical  access  to  the 
brain.  In  vivo  laser  speckle  imaging  experiments  of  mouse  cerebral  blood  vessels  allowed 
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for  through-scalp  visualization  of  microvessels,  which  was  not  possible  through  the 
uncleared  scalp  and  intact  skull. 
It  will  be  beneficial  to  investigate  the  potential  of  nc-YSZ  implant  for  facilitating 
non-invasive,  LSI-based  early  detection  of  ischemic  stroke  as  it  is  the  5th  leading  cause 
of  death  in  the  United  States  and  the  leading  cause  of  serious  long-term  disability.  LSI 
can  be  used  to  monitor  the  brain  microcirculation  through  WttB  implant  to  regionally 
identify  ischemic  cerebrovascular  blood  flow  and  determine  stereotaxic  locations  for  the 
ischemic  core,  penumbra,  oligemia  and  peri-infarct  normal  tissue. 
In  conclusion,  replacing  repeated  craniotomies  with  one-time  placement  of 
nc-YSZ  implants  will  prevent  expensive  and  highly  invasive  craniotomies.  This  would 
eventually  facilitate  clinical light-based  therapeutic  techniques  such  as 
photobiomodulation,  photodynamic  therapy,  and  optogenetics  and  noninvasively 
diagnosis  of  hematomas,  and  small  pathologic  structures  with  a  high  resolution. 
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